[
  {
    "id": 24049,
    "drug": {
      "current_status": "MARKETED",
      "id": 22978,
      "drug_code": 85559,
      "updated_date": "2025-05-15T02:32:59-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258309,
          "ingredient": {
            "id": 3728,
            "ingredient_code": 933,
            "en_name": "ZOLPIDEM TARTRATE",
            "fr_name": "Tartrate de zolpidem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370433",
      "brand_name": "SUBLINOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122857002"
    },
    "created_date": "2017-10-02T13:46:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370433",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2017-10-21T00:00:00-04:00",
    "estimated_end_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2017-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-13T20:38:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SUBLINOX",
    "en_drug_common_name": "SUBLINOX",
    "fr_drug_brand_name": "SUBLINOX",
    "fr_drug_common_name": "SUBLINOX",
    "en_ingredients": "ZOLPIDEM TARTRATE",
    "fr_ingredients": "Tartrate de zolpidem",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24052,
    "drug": {
      "current_status": "MARKETED",
      "id": 9492,
      "drug_code": 62979,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253695,
          "ingredient": {
            "id": 2656,
            "ingredient_code": 11834,
            "en_name": "IMIQUIMOD",
            "fr_name": "Imiquimod"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239505",
      "brand_name": "ALDARA P",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135820001"
    },
    "created_date": "2017-10-02T13:52:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239505",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D06BB",
    "atc_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
    "anticipated_start_date": "2017-10-27T00:00:00-04:00",
    "estimated_end_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2018-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-01-17T15:44:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ALDARA P",
    "en_drug_common_name": "ALDARA P",
    "fr_drug_brand_name": "ALDARA P",
    "fr_drug_common_name": "ALDARA P",
    "en_ingredients": "IMIQUIMOD",
    "fr_ingredients": "Imiquimod",
    "drug_strength": "5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24055,
    "drug": {
      "current_status": "MARKETED",
      "id": 7384,
      "drug_code": 49818,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253294,
          "ingredient": {
            "id": 2196,
            "ingredient_code": 7559,
            "en_name": "PREDNICARBATE",
            "fr_name": "Prednicarbate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02230642",
      "brand_name": "DERMATOP EMOLLIENT CREAM",
      "brand_name_fr": "DERMATOP CRÈME ÉMOLLIENTE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120996001"
    },
    "created_date": "2017-10-02T13:57:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230642",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2017-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-25T15:24:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DERMATOP EMOLLIENT CREAM",
    "en_drug_common_name": "DERMATOP EMOLLIENT CREAM",
    "fr_drug_brand_name": "DERMATOP EMOLLIENT CREAM",
    "fr_drug_common_name": "DERMATOP EMOLLIENT CREAM",
    "en_ingredients": "PREDNICARBATE",
    "fr_ingredients": "Prednicarbate",
    "drug_strength": "0.1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "N/A",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24098,
    "drug": {
      "current_status": "MARKETED",
      "id": 6582,
      "drug_code": 43536,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253104,
          "ingredient": {
            "id": 1932,
            "ingredient_code": 7512,
            "en_name": "DESONIDE",
            "fr_name": "Désonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02229315",
      "brand_name": "PDP-DESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9877",
      "number_of_ais": "1",
      "ai_group_no": "0106367001"
    },
    "created_date": "2017-10-02T15:51:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229315",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2017-10-02T00:00:00-04:00",
    "estimated_end_date": "2018-01-25T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-01-19T01:08:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-DESONIDE",
    "en_drug_common_name": "pdp-DESONIDE 0.05% CR 15g",
    "fr_drug_brand_name": "pdp-DESONIDE",
    "fr_drug_common_name": "pdp-DESONIDE 0.05% CR 15g",
    "en_ingredients": "DESONIDE",
    "fr_ingredients": "Désonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24103,
    "drug": {
      "current_status": "MARKETED",
      "id": 7278,
      "drug_code": 49219,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253261,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230394",
      "brand_name": "TEVA-OXYBUTYNIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2017-10-02T17:35:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230394",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2019-02-01T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2019-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OXYBUTYNIN",
    "en_drug_common_name": "OXYBUTYNIN",
    "fr_drug_brand_name": "TEVA-OXYBUTYNIN",
    "fr_drug_common_name": "OXYBUTYNIN",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24106,
    "drug": {
      "current_status": "MARKETED",
      "id": 7278,
      "drug_code": 49219,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253261,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230394",
      "brand_name": "TEVA-OXYBUTYNIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2017-10-02T17:37:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230394",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2019-02-01T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2019-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OXYBUTYNIN",
    "en_drug_common_name": "OXYBUTYNIN",
    "fr_drug_brand_name": "TEVA-OXYBUTYNIN",
    "fr_drug_common_name": "OXYBUTYNIN",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24121,
    "drug": {
      "current_status": "MARKETED",
      "id": 27482,
      "drug_code": 8972,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251115,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716618",
      "brand_name": "BETADERM CRM 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67692",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2017-10-02T18:07:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716618",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2018-10-26T00:00:00-04:00",
    "actual_start_date": "2018-10-15T00:00:00-04:00",
    "actual_end_date": "2018-10-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-30T13:47:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM CRM 0.05%",
    "en_drug_common_name": "BETADERM CRM 0.05%",
    "fr_drug_brand_name": "BETADERM CRM 0.05%",
    "fr_drug_common_name": "BETADERM CRM 0.05%",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "454G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24126,
    "drug": {
      "current_status": "MARKETED",
      "id": 4990,
      "drug_code": 2870,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250465,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00417246",
      "brand_name": "DIPROSONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51716",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2017-10-02T18:23:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00417246",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2017-10-16T00:00:00-04:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_start_date": "2017-10-04T00:00:00-04:00",
    "actual_end_date": "2017-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-11T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DIPROSONE LOTION",
    "en_drug_common_name": "Betamethasone Dipropionate Lotion",
    "fr_drug_brand_name": "DIPROSONE LOTION",
    "fr_drug_common_name": "Lotion de Dipropionate de Bétaméthasone",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "75mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24150,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8538,
      "drug_code": 60041,
      "updated_date": "2025-05-15T03:56:02-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8324143,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236754",
      "brand_name": "FLUVOXAMINE-100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450001"
    },
    "created_date": "2017-10-02T22:39:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236754",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-09T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUVOXAMINE-100",
    "en_drug_common_name": "FLUVOXAMINE",
    "fr_drug_brand_name": "FLUVOXAMINE-100",
    "fr_drug_common_name": "FLUVOXAMINE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24209,
    "drug": {
      "current_status": "MARKETED",
      "id": 8628,
      "drug_code": 60294,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253491,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236996",
      "brand_name": "LYDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2017-10-03T13:59:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236996",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2018-06-15T00:00:00-04:00",
    "actual_start_date": "2018-05-23T00:00:00-04:00",
    "actual_end_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-18T13:24:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LYDERM OINTMENT 0.05%",
    "en_drug_common_name": "Lyderm Ointment",
    "fr_drug_brand_name": "Taro Pharmaceuticals",
    "fr_drug_common_name": "Lyderm Ointment",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24212,
    "drug": {
      "current_status": "MARKETED",
      "id": 10902,
      "drug_code": 66824,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254108,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242984",
      "brand_name": "HYDROVAL CREAM 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2017-10-03T14:02:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242984",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2018-07-06T00:00:00-04:00",
    "actual_start_date": "2018-06-15T00:00:00-04:00",
    "actual_end_date": "2018-08-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-03T21:15:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "en_drug_common_name": "Hydroval Cream 0.2%",
    "fr_drug_brand_name": "Taro Pharmaceuticals",
    "fr_drug_common_name": "Hydroval Cream, 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "500 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24222,
    "drug": {
      "current_status": "DORMANT",
      "id": 28408,
      "drug_code": 90535,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 1824,
        "created_date": "2017-03-09T13:25:54-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 11915,
        "mfr_code": "",
        "name": "ID BIOMEDICAL CORPORATION OF QUEBEC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "2323 BOUL PARC TECHNOLOGIQUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "QUEBEC",
        "postal_code": "G1P 4R8",
        "post_office_box": "",
        "contact_information": "GlaxoSmithKline Customer Service: 1 800 387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8369075,
          "ingredient": {
            "id": 3954,
            "ingredient_code": 22251,
            "en_name": "HAEMAGGLUTININ-STRAIN B",
            "fr_name": "Hémagglutinine-souche B (Yamagata)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369074,
          "ingredient": {
            "id": 2024,
            "ingredient_code": 744,
            "en_name": "HAEMAGGLUTININ-STRAIN A",
            "fr_name": "Hémagglutinine-souche A (H1N1)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369073,
          "ingredient": {
            "id": 3952,
            "ingredient_code": 22250,
            "en_name": "HAEMAGGLUTININ-STRAIN B",
            "fr_name": "Hémagglutinine-souche B (Victoria)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369072,
          "ingredient": {
            "id": 2022,
            "ingredient_code": 743,
            "en_name": "HAEMAGGLUTININ-STRAIN A",
            "fr_name": "Hémagglutinine-souche A (H3N2)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02420783",
      "brand_name": "FLULAVAL TETRA",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIAL, WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0455410001"
    },
    "created_date": "2017-10-03T15:14:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420783",
    "company_name": "ID BIOMEDICAL CORPORATION OF QUEBEC",
    "atc_number": "J07BB",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2017-09-27T00:00:00-04:00",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-09-27T00:00:00-04:00",
    "actual_end_date": "2018-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-31T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "2017-2018 flu vaccine production less that anticipated. Supply disruption in the private market. Doses reserved for public vaccination programs.",
    "fr_comments": "Production 2017-2018 de vaccins influenza plus faible qu'anticipé. Interruption de l'offre pour le marché privé.  Doses réservées pour les programmes de vaccination publiques.",
    "en_drug_brand_name": "FLULAVAL TETRA",
    "en_drug_common_name": "Quadrivalent Influenza Vaccine (Split Virion, Inactivated)",
    "fr_drug_brand_name": "FluLaval Tetra",
    "fr_drug_common_name": "Vaccin antigrippal quadrivalent (à virion fragmenté, inactivé)",
    "en_ingredients": "HAEMAGGLUTININ-STRAIN B\r\nHAEMAGGLUTININ-STRAIN B\r\nHAEMAGGLUTININ-STRAIN A\r\nHAEMAGGLUTININ-STRAIN A",
    "fr_ingredients": "Hémagglutinine souche B\r\nHémagglutinine souche B\r\nHémagglutinine souche A\r\nHémagglutinine souche A",
    "drug_strength": "15MCG\r\n15MCG\r\n15MCG\r\n15MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 vial X 10 doses",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24232,
    "drug": {
      "current_status": "MARKETED",
      "id": 28400,
      "drug_code": 90524,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 1824,
        "created_date": "2017-03-09T13:25:54-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 11915,
        "mfr_code": "",
        "name": "ID BIOMEDICAL CORPORATION OF QUEBEC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "2323 BOUL PARC TECHNOLOGIQUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "QUEBEC",
        "postal_code": "G1P 4R8",
        "post_office_box": "",
        "contact_information": "GlaxoSmithKline Customer Service: 1 800 387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8260293,
          "ingredient": {
            "id": 2024,
            "ingredient_code": 744,
            "en_name": "HAEMAGGLUTININ-STRAIN A",
            "fr_name": "Hémagglutinine-souche A (H1N1)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260292,
          "ingredient": {
            "id": 2022,
            "ingredient_code": 743,
            "en_name": "HAEMAGGLUTININ-STRAIN A",
            "fr_name": "Hémagglutinine-souche A (H3N2)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260291,
          "ingredient": {
            "id": 2020,
            "ingredient_code": 742,
            "en_name": "HAEMAGGLUTININ-STRAIN B",
            "fr_name": "Hémaglutinine-souche B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02420686",
      "brand_name": "FLUVIRAL",
      "brand_name_fr": "",
      "descriptor": "TRIVALENT, SPLIT-VIRION, INACTIVATED INFLUENZA VACCINE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0324197003"
    },
    "created_date": "2017-10-03T15:31:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420686",
    "company_name": "ID BIOMEDICAL CORPORATION OF QUEBEC",
    "atc_number": "J07BB",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2017-09-27T00:00:00-04:00",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-09-27T00:00:00-04:00",
    "actual_end_date": "2018-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-13T15:32:58-04:00",
    "status": "resolved",
    "en_comments": "2017-2018 flu vaccine production less that anticipated. Supply disruption in the private market. Doses reserved for public vaccination programs.",
    "fr_comments": "Production 2017-2018 de vaccins influenza plus faible qu'anticipée. Interruption de l'offre pour le marché privé.  Doses réservées pour les programmes de vaccination publiques.",
    "en_drug_brand_name": "FLUVIRAL",
    "en_drug_common_name": "Trivalent Influenza Vaccine (Split Virion, Inactivated)",
    "fr_drug_brand_name": "Fluviral",
    "fr_drug_common_name": "Vaccin antigrippal trivalent (à virion fragmenté, inactivé)",
    "en_ingredients": "HAEMAGGLUTININ-STRAIN B\r\nHAEMAGGLUTININ-STRAIN A\r\nHAEMAGGLUTININ-STRAIN A",
    "fr_ingredients": "Hémaglutinine-souche B\r\nHémaglutinine-souche A\r\nHémaglutinine-souche A",
    "drug_strength": "15MCG\r\n15MCG\r\n15MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 vial X 10 doses",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24237,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14260,
      "drug_code": 7434,
      "updated_date": "2025-12-03T01:02:27-05:00",
      "company": {
        "id": 126,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 8541,
        "mfr_code": "",
        "name": "VITA HEALTH PRODUCTS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 BEGHIN AVENUE",
        "province": "MANITOBA",
        "country": "CANADA",
        "city": "WINNIPEG",
        "postal_code": "R2J 3W2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8282097,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8282096,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8282095,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00706221",
      "brand_name": "ACETAMINOPHEN 325 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "65439",
      "number_of_ais": "3",
      "ai_group_no": "0311391002"
    },
    "created_date": "2017-10-03T18:32:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00706221",
    "company_name": "VITA HEALTH PRODUCTS INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2017-09-29T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "No supply remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-04T17:25:19-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACETAMINOPHEN 325 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE",
    "en_drug_common_name": "Acetaminophen 325 mg with 15 mg Caffeine and 8 mg Codeine Phosphate",
    "fr_drug_brand_name": "Acétaminophène 325 mg avec 15 mg de caféine et 8 mg de phosphate de codéine",
    "fr_drug_common_name": "Acétaminophène 325 mg avec 15 mg de caféine et 8 mg de phosphate de codéine",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "325MG\r\n8MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30, 50, 100, 200",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 24257,
    "drug": {
      "current_status": "MARKETED",
      "id": 14406,
      "drug_code": 74650,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255189,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261081",
      "brand_name": "APO-DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106303001"
    },
    "created_date": "2017-10-04T01:02:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261081",
    "company_name": "APOTEX INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T15:04:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DEXAMETHASONE",
    "en_drug_common_name": "DEXAMETHASONE",
    "fr_drug_brand_name": "APO-DEXAMETHASONE",
    "fr_drug_common_name": "DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24262,
    "drug": {
      "current_status": "MARKETED",
      "id": 16360,
      "drug_code": 77143,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255828,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285940",
      "brand_name": "APO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2017-10-04T01:14:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285940",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2018-01-12T00:00:00-05:00",
    "estimated_end_date": "2018-03-14T00:00:00-04:00",
    "actual_start_date": "2018-01-05T00:00:00-05:00",
    "actual_end_date": "2018-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-15T12:30:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "APO-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24265,
    "drug": {
      "current_status": "MARKETED",
      "id": 4282,
      "drug_code": 20190,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252685,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252684,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02195968",
      "brand_name": "APO-LEVOCARB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82493",
      "number_of_ais": "2",
      "ai_group_no": "0210315001"
    },
    "created_date": "2017-10-04T01:19:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02195968",
    "company_name": "APOTEX INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-09T12:56:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVOCARB - TAB 25MG/250MG",
    "en_drug_common_name": "LEVOCArB",
    "fr_drug_brand_name": "APO-LEVOCARB - TAB 25MG/250MG",
    "fr_drug_common_name": "LEVOCARB",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24268,
    "drug": {
      "current_status": "MARKETED",
      "id": 14910,
      "drug_code": 75305,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255339,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02267640",
      "brand_name": "AA-MEDROXY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339007"
    },
    "created_date": "2017-10-04T01:26:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267640",
    "company_name": "APOTEX INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2017-11-15T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-02T14:45:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MEDROXY",
    "en_drug_common_name": "MEDROXYPROGESTERONE",
    "fr_drug_brand_name": "APO-MEDROXY",
    "fr_drug_common_name": "medroxyprogesterone",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24271,
    "drug": {
      "current_status": "MARKETED",
      "id": 16414,
      "drug_code": 77208,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255852,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286637",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928003"
    },
    "created_date": "2017-10-04T01:31:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286637",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-10-25T00:00:00-04:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24274,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2017-10-04T01:34:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-02-28T00:00:00-05:00",
    "actual_start_date": "2017-12-13T00:00:00-05:00",
    "actual_end_date": "2018-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-01T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24277,
    "drug": {
      "current_status": "MARKETED",
      "id": 22186,
      "drug_code": 84561,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257943,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360640",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-10-04T01:39:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360640",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-02-28T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-29T13:00:51-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24280,
    "drug": {
      "current_status": "MARKETED",
      "id": 11148,
      "drug_code": 67424,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254185,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243506",
      "brand_name": "APO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2017-10-04T01:47:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243506",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-07T16:13:36-05:00",
    "status": "resolved",
    "en_comments": "30 bls available",
    "en_drug_brand_name": "APO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "APO-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24283,
    "drug": {
      "current_status": "MARKETED",
      "id": 11150,
      "drug_code": 67425,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254186,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243507",
      "brand_name": "APO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2017-10-04T01:50:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243507",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-07T16:15:52-05:00",
    "status": "resolved",
    "en_comments": "30 bls available",
    "en_drug_brand_name": "APO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "APO-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24328,
    "drug": {
      "current_status": "MARKETED",
      "id": 2966,
      "drug_code": 17246,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252202,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02139332",
      "brand_name": "APO-BACLOFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79399",
      "number_of_ais": "1",
      "ai_group_no": "0113246001"
    },
    "created_date": "2017-10-04T12:49:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139332",
    "company_name": "APOTEX INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-07T14:16:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BACLOFEN TABLETS - 10MG",
    "en_drug_common_name": "BACLOFEN",
    "fr_drug_brand_name": "APO-BACLOFEN TABLETS - 10MG",
    "fr_drug_common_name": "BACLOFEN",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 24363,
    "drug": {
      "current_status": "MARKETED",
      "id": 15714,
      "drug_code": 76425,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255618,
          "ingredient": {
            "id": 3284,
            "ingredient_code": 918,
            "en_name": "MIDODRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de midodrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278677",
      "brand_name": "APO-MIDODRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123066001"
    },
    "created_date": "2017-10-04T16:20:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278677",
    "company_name": "AA PHARMA INC",
    "atc_number": "C01CA17",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2017-10-30T00:00:00-04:00",
    "actual_start_date": "2017-10-04T00:00:00-04:00",
    "actual_end_date": "2017-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-13T12:38:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDODRINE",
    "en_drug_common_name": "MIDODRINE",
    "fr_drug_brand_name": "MIDODRINE",
    "fr_drug_common_name": "MIDODRINE",
    "en_ingredients": "MIDODRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de midodrine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24465,
    "drug": {
      "current_status": "MARKETED",
      "id": 1380,
      "drug_code": 12993,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 17273,
        "created_date": "2023-06-19T22:00:16-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 18865,
        "mfr_code": "",
        "name": "ESSENTIAL PHARMA SWITZERLAND GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "LANDIS + GYR-STRASSE 1",
        "province": "--",
        "country": "SWITZERLAND",
        "city": "ZUG",
        "postal_code": "6300",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251713,
          "ingredient": {
            "id": 794,
            "ingredient_code": 11372,
            "en_name": "APRACLONIDINE",
            "fr_name": "ApraclonidinE (Chlorhydrate d'apraclonidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00888354",
      "brand_name": "IOPIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74244",
      "number_of_ais": "1",
      "ai_group_no": "0122471001"
    },
    "created_date": "2017-10-05T14:21:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00888354",
    "company_name": "ALCON CANADA INC",
    "atc_number": "S01EA03",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2018-01-24T00:00:00-05:00",
    "actual_start_date": "2017-10-03T00:00:00-04:00",
    "actual_end_date": "2018-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IOPIDINE OPH SOL 1%",
    "en_drug_common_name": "APRACLONIDINE HCL",
    "fr_drug_brand_name": "IOPIDINE",
    "fr_drug_common_name": "APRACLONIDINE",
    "en_ingredients": "APRACLONIDINE",
    "fr_ingredients": "APRACLONIDINE",
    "drug_strength": "1%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "(2 x 0.1mL)  x 12",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24661,
    "drug": {
      "current_status": "MARKETED",
      "id": 6278,
      "drug_code": 43104,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253030,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02213451",
      "brand_name": "VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9396",
      "number_of_ais": "1",
      "ai_group_no": "0108887007"
    },
    "created_date": "2017-10-06T14:04:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213451",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03CC02",
    "atc_description": "ADRENERGICS FOR SYSTEMIC USE",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-10-03T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-16T17:19:52-05:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour un approvisionnement d’urgence, communiquez avec le Service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML)",
    "en_drug_common_name": "salbutamol sulfate for injection",
    "fr_drug_brand_name": "VENTOLIN solution pour perfusion i.v.",
    "fr_drug_common_name": "sulfate de salbutamol pour injection",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 x 5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24666,
    "drug": {
      "current_status": "MARKETED",
      "id": 24258,
      "drug_code": 86863,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8258726,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8258725,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02382822",
      "brand_name": "CLINDOXYL ADV GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561002"
    },
    "created_date": "2017-10-06T14:13:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382822",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AF51",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2017-11-24T00:00:00-05:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2017-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-22T16:43:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDOXYL ADV GEL",
    "en_drug_common_name": "clindamycin and benzoyl peroxide gel",
    "fr_drug_brand_name": "Gel CLINDOXYL ADV",
    "fr_drug_common_name": "gel de clindamycine et de peroxyde de benzoyle",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle\r\nClindamycine",
    "drug_strength": "3%\r\n1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "45g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24674,
    "drug": {
      "current_status": "MARKETED",
      "id": 1892,
      "drug_code": 1403,
      "updated_date": "2025-12-03T00:30:19-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250267,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00028606",
      "brand_name": "ALDACTONE 25 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "39812",
      "number_of_ais": "1",
      "ai_group_no": "0106462001"
    },
    "created_date": "2017-10-06T15:56:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00028606",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C03DA01",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-09-07T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Current inventory on allocation. Other presentation available: Aldactone 100mg",
    "fr_comments": "Inventaire en allocation. Autre présentation disponible: Aldactone 100mg",
    "en_drug_brand_name": "ALDACTONE 25 MG",
    "en_drug_common_name": "ALDACTONE",
    "fr_drug_brand_name": "ALDACTONE 25 MG",
    "fr_drug_common_name": "ALDACTONE",
    "en_ingredients": "SPIRONOLACTONE",
    "fr_ingredients": "Spironolactone",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24711,
    "drug": {
      "current_status": "MARKETED",
      "id": 4078,
      "drug_code": 19894,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252575,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216132",
      "brand_name": "PMS-LITHIUM CARBONATE - CAP 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82192",
      "number_of_ais": "1",
      "ai_group_no": "0101163001"
    },
    "created_date": "2017-10-06T19:03:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02216132",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Packaging size of 100 is still available",
    "fr_discontinuation_comments": "Le format de 100 restera disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-06T19:04:49-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-LITHIUM CARBONATE - CAP 150MG",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "PMS - LITHIUM CARBONATE",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24716,
    "drug": {
      "current_status": "DORMANT",
      "id": 4112,
      "drug_code": 19933,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367035,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216140",
      "brand_name": "PMS-LITHIUM CARBONATE - CAP 300MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82232",
      "number_of_ais": "1",
      "ai_group_no": "0101163002"
    },
    "created_date": "2017-10-06T19:10:07-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02216140",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "The packaging size of 100 will still be available.",
    "fr_discontinuation_comments": "Le format de 100 restera disponible.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-06T19:10:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-LITHIUM CARBONATE - CAP 300MG",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "PMS - LITHIUM CARBONATE",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24738,
    "drug": {
      "current_status": "MARKETED",
      "id": 3014,
      "drug_code": 1745,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250310,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250309,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250308,
          "ingredient": {
            "id": 8,
            "ingredient_code": 1074,
            "en_name": "SODIUM LACTATE",
            "fr_name": "Lactate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250307,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00039470",
      "brand_name": "LACTATED RINGER'S INJECTION",
      "brand_name_fr": "RINGER-LACTATE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43673",
      "number_of_ais": "4",
      "ai_group_no": "0400132001"
    },
    "created_date": "2017-10-06T19:43:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00039470",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "B05BB01",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2017-10-06T00:00:00-04:00",
    "estimated_end_date": "2017-11-11T00:00:00-05:00",
    "actual_end_date": "2017-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-31T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LACTATED RINGER'S INJECTION",
    "en_drug_common_name": "Lactated Ringer’s Injection USP",
    "fr_drug_brand_name": "Hospira Healthcare Corporation",
    "fr_drug_common_name": "Ringer-Lactate injectable USP",
    "en_ingredients": "SODIUM LACTATE\r\nCALCIUM CHLORIDE\r\nPOTASSIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Lactate de sodium\r\nChlorure de calcium\r\nChlorure de potassium\r\nChlorure de sodium",
    "drug_strength": "3.1MG\r\n0.2MG\r\n0.3MG\r\n6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24761,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25524,
      "drug_code": 87954,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8352202,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394375",
      "brand_name": "LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2017-10-06T20:01:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394375",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "hc_updated_date": "2023-07-11T14:50:09-04:00",
    "actual_start_date": "2018-10-06T00:00:00-04:00",
    "actual_end_date": "2023-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-11T14:50:16-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "fr_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "en_drug_brand_name": "LOSARTAN",
    "en_drug_common_name": "LOSARTAN",
    "fr_drug_brand_name": "LOSARTAN",
    "fr_drug_common_name": "LOSARTAN",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24792,
    "drug": {
      "current_status": "MARKETED",
      "id": 6642,
      "drug_code": 43947,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253137,
          "ingredient": {
            "id": 1450,
            "ingredient_code": 8872,
            "en_name": "GLUTAMIC ACID",
            "fr_name": "Acide glutamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.02",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253136,
          "ingredient": {
            "id": 1452,
            "ingredient_code": 9397,
            "en_name": "L-ASPARTIC ACID",
            "fr_name": "Acide L-aspartique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253135,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.02",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253134,
          "ingredient": {
            "id": 376,
            "ingredient_code": 10223,
            "en_name": "PHENYLALANINE",
            "fr_name": "Phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253133,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.06",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253132,
          "ingredient": {
            "id": 402,
            "ingredient_code": 9929,
            "en_name": "ISOLEUCINE",
            "fr_name": "Isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.08",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253131,
          "ingredient": {
            "id": 400,
            "ingredient_code": 9928,
            "en_name": "VALINE",
            "fr_name": "Valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.44",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253130,
          "ingredient": {
            "id": 1494,
            "ingredient_code": 2963,
            "en_name": "ALANINE",
            "fr_name": "Alanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.76",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253129,
          "ingredient": {
            "id": 382,
            "ingredient_code": 10239,
            "en_name": "LEUCINE",
            "fr_name": "Leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.08",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253128,
          "ingredient": {
            "id": 394,
            "ingredient_code": 9396,
            "en_name": "PROLINE",
            "fr_name": "Proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.34",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253127,
          "ingredient": {
            "id": 384,
            "ingredient_code": 10242,
            "en_name": "ARGININE",
            "fr_name": "Arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.96",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253126,
          "ingredient": {
            "id": 396,
            "ingredient_code": 9750,
            "en_name": "TYROSINE",
            "fr_name": "Tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253125,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.18",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253124,
          "ingredient": {
            "id": 440,
            "ingredient_code": 7216,
            "en_name": "DL-METHIONINE",
            "fr_name": "DL-méthionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.76",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253123,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.32",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253122,
          "ingredient": {
            "id": 386,
            "ingredient_code": 10243,
            "en_name": "THREONINE",
            "fr_name": "Thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.98",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253121,
          "ingredient": {
            "id": 1142,
            "ingredient_code": 9806,
            "en_name": "LYSINE",
            "fr_name": "Lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.35",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02141450",
      "brand_name": "20% PROSOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9160",
      "number_of_ais": "17",
      "ai_group_no": "1727121002"
    },
    "created_date": "2017-10-10T13:41:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02141450",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA01",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2017-11-15T00:00:00-05:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2017-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-22T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Customers can use the following alternate code upon their clinical judgement:\r\nJB6584- Travasol 10% 1000 ml",
    "fr_comments": "En s’appuyant sur leur jugement clinique, Les clients peuvent utiliser le code de produit de rechange suivants: \r\n•\tTravasol à 10 % - JB6584 1000ml",
    "en_drug_brand_name": "20% PROSOL",
    "en_drug_common_name": "20% PROSOL",
    "fr_drug_brand_name": "20% PROSOL",
    "fr_drug_common_name": "20% PROSOL",
    "en_ingredients": "PHENYLALANINE\r\nHISTIDINE\r\nTRYPTOPHAN\r\nLEUCINE\r\nARGININE\r\nTHREONINE\r\nALANINE\r\nDL-METHIONINE\r\nGLYCINE\r\nGLUTAMIC ACID\r\nPROLINE\r\nL-ASPARTIC ACID\r\nTYROSINE\r\nLYSINE\r\nSERINE\r\nVALINE\r\nISOLEUCINE",
    "fr_ingredients": "Phénylalanine\r\nHistidine\r\nTryptophane\r\nLeucine\r\nArginine\r\nThréonine\r\nAlanine\r\nDL-méthionine\r\nGlycine\r\nAcide glutamique\r\nProline\r\nAcide L-aspartique\r\nTyrosine\r\nLysine\r\nSérine\r\nValine\r\nIsoleucine",
    "drug_strength": "1G\r\n1.18G\r\n0.32G\r\n1.08G\r\n1.96G\r\n0.98G\r\n2.76G\r\n0.76G\r\n2.06G\r\n1.02G\r\n1.34G\r\n0.6G\r\n0.05G\r\n1.35G\r\n1.02G\r\n1.44G\r\n1.08G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "2000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24803,
    "drug": {
      "current_status": "MARKETED",
      "id": 11184,
      "drug_code": 67513,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254202,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243595",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732003"
    },
    "created_date": "2017-10-10T14:13:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243595",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA07",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2017-11-02T00:00:00-04:00",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-14T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "200MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60 DOSE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24836,
    "drug": {
      "current_status": "MARKETED",
      "id": 17936,
      "drug_code": 79038,
      "updated_date": "2025-05-15T02:32:05-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8256298,
          "ingredient": {
            "id": 432,
            "ingredient_code": 1196,
            "en_name": "CLOZAPINE",
            "fr_name": "Clozapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02305003",
      "brand_name": "GEN-CLOZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122583003"
    },
    "created_date": "2017-10-10T14:53:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305003",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH02",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-10-18T00:00:00-04:00",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_start_date": "2017-10-19T00:00:00-04:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-21T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GEN-CLOZAPINE",
    "en_drug_common_name": "CLOZAPINE",
    "fr_drug_brand_name": "GEN-CLOZAPINE",
    "fr_drug_common_name": "CLOZAPINE",
    "en_ingredients": "CLOZAPINE",
    "fr_ingredients": "Clozapine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24841,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27022,
      "drug_code": 89264,
      "updated_date": "2025-05-15T04:21:14-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353237,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02407930",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315007"
    },
    "created_date": "2017-10-10T14:57:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407930",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01XA01",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2017-10-04T00:00:00-04:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T14:46:05-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 51674.",
    "fr_comments": "discontinued in ID 51674.",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "fr_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "fr_drug_common_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "Vancomycin Hydrochloride",
    "drug_strength": "5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1VL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24866,
    "drug": {
      "current_status": "MARKETED",
      "id": 11186,
      "drug_code": 67514,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254203,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243596",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732004"
    },
    "created_date": "2017-10-10T16:30:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243596",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA07",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2017-10-30T00:00:00-04:00",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-20T14:05:32-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "400MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "30DOSE",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24907,
    "drug": {
      "current_status": "MARKETED",
      "id": 29104,
      "drug_code": 91138,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260560,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426838",
      "brand_name": "DOCUSATE SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2017-10-10T17:50:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426838",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "A06AA02",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2017-10-10T00:00:00-04:00",
    "estimated_end_date": "2017-10-27T00:00:00-04:00",
    "actual_end_date": "2017-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-16T13:09:15-05:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "DOCUSATE SODIUM",
    "en_drug_common_name": "DOCUSATE SODIUM CAPS",
    "fr_drug_brand_name": "DOCUSATE SODIUM",
    "fr_drug_common_name": "DOCUSATE SODIUM CAPS",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 24913,
    "drug": {
      "current_status": "MARKETED",
      "id": 21468,
      "drug_code": 83848,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257669,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353261",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-10-10T17:53:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353261",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-16T00:00:00-04:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2017-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-27T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN CAPS",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN CAPS",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25088,
    "drug": {
      "current_status": "MARKETED",
      "id": 276,
      "drug_code": 10748,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251380,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251379,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00611174",
      "brand_name": "LOTRIDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70771",
      "number_of_ais": "2",
      "ai_group_no": "0216399001"
    },
    "created_date": "2017-10-10T19:04:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00611174",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D01AC20",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "anticipated_start_date": "2017-10-16T00:00:00-04:00",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-10-11T00:00:00-04:00",
    "actual_end_date": "2017-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-16T14:33:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTRIDERM CREAM",
    "en_drug_common_name": "Clotrimazole and Betamethasone Dipropionate Cream",
    "fr_drug_brand_name": "LOTRIDERM CRÈME",
    "fr_drug_common_name": "Crème de Clotrimazole et de Dipropionate de Bétaméthasone",
    "en_ingredients": "BETAMETHASONE\r\nCLOTRIMAZOLE",
    "fr_ingredients": "Bétaméthasone\r\nClotrimazole",
    "drug_strength": "0.05%\r\n1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25102,
    "drug": {
      "current_status": "MARKETED",
      "id": 23746,
      "drug_code": 86409,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258552,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378272",
      "brand_name": "NUCYNTA IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846001"
    },
    "created_date": "2017-10-10T19:09:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378272",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-12-30T00:00:00-05:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T14:07:28-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "NUCYNTA IR",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta IR",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25108,
    "drug": {
      "current_status": "MARKETED",
      "id": 23748,
      "drug_code": 86410,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258553,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378280",
      "brand_name": "NUCYNTA IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846006"
    },
    "created_date": "2017-10-10T19:14:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378280",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-11-21T00:00:00-05:00",
    "actual_end_date": "2017-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NUCYNTA IR",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta IR",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25111,
    "drug": {
      "current_status": "MARKETED",
      "id": 23750,
      "drug_code": 86411,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258554,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378299",
      "brand_name": "NUCYNTA IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846002"
    },
    "created_date": "2017-10-10T19:20:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378299",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-12-30T00:00:00-05:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-04T15:31:00-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "NUCYNTA IR",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta IR",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25117,
    "drug": {
      "current_status": "MARKETED",
      "id": 27802,
      "drug_code": 90016,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260105,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415577",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846001"
    },
    "created_date": "2017-10-10T19:27:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415577",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-12-30T00:00:00-05:00",
    "estimated_end_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2018-02-01T00:00:00-05:00",
    "actual_end_date": "2018-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-17T14:22:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta Libération Prolongée",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25122,
    "drug": {
      "current_status": "MARKETED",
      "id": 27804,
      "drug_code": 90017,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260106,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415585",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846002"
    },
    "created_date": "2017-10-10T19:29:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415585",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-12-30T00:00:00-05:00",
    "actual_end_date": "2017-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-17T14:25:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta Libération Prolongée",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25129,
    "drug": {
      "current_status": "MARKETED",
      "id": 27806,
      "drug_code": 90018,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260107,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415593",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846003"
    },
    "created_date": "2017-10-10T19:31:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415593",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-12-30T00:00:00-05:00",
    "estimated_end_date": "2017-12-06T00:00:00-05:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T14:03:41-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta Libération Prolongée",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25134,
    "drug": {
      "current_status": "MARKETED",
      "id": 27808,
      "drug_code": 90019,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260108,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415607",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846004"
    },
    "created_date": "2017-10-10T19:33:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415607",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-02-27T00:00:00-05:00",
    "actual_end_date": "2018-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-17T14:23:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta Libération Prolongée",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25141,
    "drug": {
      "current_status": "MARKETED",
      "id": 27810,
      "drug_code": 90020,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260109,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415615",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846005"
    },
    "created_date": "2017-10-10T19:35:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415615",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX06",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-01-15T00:00:00-05:00",
    "estimated_end_date": "2018-02-19T00:00:00-05:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T14:12:54-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "Nucynta",
    "fr_drug_brand_name": "Nucynta Libération Prolongée",
    "fr_drug_common_name": "Nucynta",
    "en_ingredients": "Tapentadol",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25154,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25530,
      "drug_code": 87957,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8352207,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8352206,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394405",
      "brand_name": "LOSARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2017-10-10T19:43:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394405",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "hc_updated_date": "2023-07-11T14:47:16-04:00",
    "actual_start_date": "2018-10-10T00:00:00-04:00",
    "actual_end_date": "2023-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-11T14:47:18-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "fr_comments": "Discontinued as of July 10, 2023 – Discontinué en date du 10 juillet 2023.",
    "en_drug_brand_name": "LOSARTAN-HCTZ",
    "en_drug_common_name": "LOSARTAN-HCTZ",
    "fr_drug_brand_name": "LOSARTAN-HCTZ",
    "fr_drug_common_name": "LOSARTAN-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25157,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13902,
      "drug_code": 73852,
      "updated_date": "2025-05-15T04:08:42-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8339982,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02253550",
      "brand_name": "MEDROXY-2.5",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339004"
    },
    "created_date": "2017-10-10T19:45:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02253550",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G03DA02",
    "atc_description": "PROGESTOGENS",
    "actual_start_date": "2017-10-10T00:00:00-04:00",
    "actual_end_date": "2017-11-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-08T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MEDROXY-2.5",
    "en_drug_common_name": "MEDROXY-2.5",
    "fr_drug_brand_name": "MEDROXY-2.5",
    "fr_drug_common_name": "MEDROXY-2.5",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25160,
    "drug": {
      "current_status": "MARKETED",
      "id": 19776,
      "drug_code": 81117,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256906,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325810",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2017-10-10T19:48:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325810",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N04BC05",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2018-08-21T00:00:00-04:00",
    "actual_end_date": "2018-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-12-21T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25163,
    "drug": {
      "current_status": "MARKETED",
      "id": 28784,
      "drug_code": 90902,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260445,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424312",
      "brand_name": "SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261002"
    },
    "created_date": "2017-10-10T19:50:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424312",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04BE03",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-10-10T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25166,
    "drug": {
      "current_status": "MARKETED",
      "id": 27596,
      "drug_code": 89826,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259974,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413612",
      "brand_name": "TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2017-10-10T19:52:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413612",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04CA02",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "actual_start_date": "2017-10-10T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-30T14:43:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN CR",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25204,
    "drug": {
      "current_status": "DORMANT",
      "id": 13412,
      "drug_code": 73095,
      "updated_date": "2025-05-15T06:55:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367669,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248727",
      "brand_name": "APO-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323004"
    },
    "created_date": "2017-10-11T11:53:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248727",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-27T15:14:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "APO-ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25207,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11120,
      "drug_code": 67343,
      "updated_date": "2025-05-15T04:02:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8333750,
          "ingredient": {
            "id": 954,
            "ingredient_code": 1205,
            "en_name": "DICLOFENAC POTASSIUM",
            "fr_name": "Diclofénac potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243433",
      "brand_name": "APO-DICLO RAPIDE 50 MG TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122516001"
    },
    "created_date": "2017-10-11T12:19:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243433",
    "company_name": "APOTEX INC",
    "atc_number": "M01AB05",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2017-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-22T12:50:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLO RAPIDE 50 MG TABLETS",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "APO-DICLO RAPIDE 50 MG TABLETS",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC POTASSIUM",
    "fr_ingredients": "Diclofénac potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25210,
    "drug": {
      "current_status": "MARKETED",
      "id": 20002,
      "drug_code": 81335,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257040,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02327856",
      "brand_name": "APO-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048004"
    },
    "created_date": "2017-10-11T12:26:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327856",
    "company_name": "APOTEX INC",
    "atc_number": "C03AA03",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2018-03-16T00:00:00-04:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-06T15:45:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDRO",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "APO-HYDRO",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25214,
    "drug": {
      "current_status": "MARKETED",
      "id": 22468,
      "drug_code": 84905,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258068,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364115",
      "brand_name": "APO-HYDROMORPHONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698004"
    },
    "created_date": "2017-10-11T12:31:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364115",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA03",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-23T02:18:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROMORPHONE",
    "en_drug_common_name": "HYDROMORPHONE HCL",
    "fr_drug_brand_name": "APO-HYDROMORPHONE",
    "fr_drug_common_name": "HYDROMORPHONE HCL",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25287,
    "drug": {
      "current_status": "DORMANT",
      "id": 24760,
      "drug_code": 87325,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368809,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8368808,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387662",
      "brand_name": "APO-IRBESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2017-10-11T17:13:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387662",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2017-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-15T23:47:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IRBESARTAN/HCTZ",
    "en_drug_common_name": "IRBESARTAN/HCTZ",
    "fr_drug_brand_name": "APO-IRBESARTAN/HCTZ",
    "fr_drug_common_name": "IRBESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25292,
    "drug": {
      "current_status": "MARKETED",
      "id": 20168,
      "drug_code": 81611,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257152,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330377",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2017-10-11T17:22:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330377",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA04",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-23T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25296,
    "drug": {
      "current_status": "MARKETED",
      "id": 9208,
      "drug_code": 62067,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253603,
          "ingredient": {
            "id": 2612,
            "ingredient_code": 946,
            "en_name": "NABUMETONE",
            "fr_name": "Nabumétone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238639",
      "brand_name": "NABUMETONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122821001"
    },
    "created_date": "2017-10-11T17:25:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238639",
    "company_name": "APOTEX INC",
    "atc_number": "M01AX01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-08-15T00:00:00-04:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NABUMETONE",
    "en_drug_common_name": "NABUMETONE",
    "fr_drug_brand_name": "APO-NABUMETONE",
    "fr_drug_common_name": "NABUMETONE",
    "en_ingredients": "NABUMETONE",
    "fr_ingredients": "Nabumétone",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25299,
    "drug": {
      "current_status": "MARKETED",
      "id": 30822,
      "drug_code": 92924,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261386,
          "ingredient": {
            "id": 2142,
            "ingredient_code": 20300,
            "en_name": "NALTREXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naltrexone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444275",
      "brand_name": "APO-NALTREXONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118591001"
    },
    "created_date": "2017-10-11T17:28:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444275",
    "company_name": "APOTEX INC",
    "atc_number": "N07BB04",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2017-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T15:05:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NALTREXONE",
    "en_drug_common_name": "NALTREXONE",
    "fr_drug_brand_name": "APO-NALTREXONE",
    "fr_drug_common_name": "NALTREXONE",
    "en_ingredients": "NALTREXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naltrexone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25304,
    "drug": {
      "current_status": "MARKETED",
      "id": 22634,
      "drug_code": 85159,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258152,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366762",
      "brand_name": "APO-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552001"
    },
    "created_date": "2017-10-11T17:54:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366762",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA05",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-13T12:02:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "APO-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "20.0MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25312,
    "drug": {
      "current_status": "MARKETED",
      "id": 14266,
      "drug_code": 74343,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8255143,
          "ingredient": {
            "id": 2428,
            "ingredient_code": 11461,
            "en_name": "IRINOTECAN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'irinotécan (Chlorhydrate trihydraté d'irinotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02258218",
      "brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132910001"
    },
    "created_date": "2017-10-11T18:12:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258218",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "L01XX19",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "actual_start_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2018-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-19T16:09:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "IRINOTECAN",
    "fr_drug_brand_name": "IRINOTECAN HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "IRINOTECAN",
    "en_ingredients": "IRINOTECAN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'irinotécan",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1x5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25320,
    "drug": {
      "current_status": "MARKETED",
      "id": 11916,
      "drug_code": 69741,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254422,
          "ingredient": {
            "id": 2962,
            "ingredient_code": 12713,
            "en_name": "GANIRELIX",
            "fr_name": "Ganirélix (Acétate de ganirélix)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245641",
      "brand_name": "ORGALUTRAN",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146941001"
    },
    "created_date": "2017-10-11T18:21:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245641",
    "company_name": "MERCK CANADA INC",
    "atc_number": "H01CC01",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "anticipated_start_date": "2017-11-08T00:00:00-05:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2017-11-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-07T19:29:36-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ORGALUTRAN",
    "en_drug_common_name": "Ganirelix Acetate Injection",
    "fr_drug_brand_name": "ORGALUTRAN",
    "fr_drug_common_name": "Injection d’acétate de ganirelix",
    "en_ingredients": "GANIRELIX",
    "fr_ingredients": "ganirelix",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "0.5ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25606,
    "drug": {
      "current_status": "MARKETED",
      "id": 720,
      "drug_code": 11625,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251556,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251555,
          "ingredient": {
            "id": 466,
            "ingredient_code": 2322,
            "en_name": "DOPAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dopamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00761826",
      "brand_name": "DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72440",
      "number_of_ais": "2",
      "ai_group_no": "0217918003"
    },
    "created_date": "2017-10-11T21:44:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00761826",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C01CA04",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2017-10-12T00:00:00-04:00",
    "estimated_end_date": "2018-03-01T00:00:00-05:00",
    "actual_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2018-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T15:09:21-05:00",
    "status": "resolved",
    "en_comments": "Product is on backorder. Users should proceed with adopting conservation strategies or finding clinical alternatives. Other Dopamine concentrations are available.  Contact your local Baxter representative with questions.",
    "fr_comments": "Le produit est en rupture de stock. Les utilisateurs devraient adopter des stratégies de conservation ou trouver des alternatives cliniques . D'autres concentrations de dopamine sont Disponibles. Si vous avez des questions veuillez communiquer avec votre chef de territoire de Baxter.",
    "en_drug_brand_name": "DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP",
    "en_drug_common_name": "DOPAMINE HCL 1.6MG/ML",
    "fr_drug_brand_name": "DOPAMINE HCL 1.6MG/ML",
    "fr_drug_common_name": "DOPAMINE HCL 1.6MG/ML",
    "en_ingredients": "DOPAMINE HYDROCHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorhydrate de dopamine\r\nDextrose",
    "drug_strength": "1.6MG\r\n50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25636,
    "drug": {
      "current_status": "MARKETED",
      "id": 3490,
      "drug_code": 18779,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252382,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02167794",
      "brand_name": "APO-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81053",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2017-10-12T14:18:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02167794",
    "company_name": "APOTEX INC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-19T13:37:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SOTALOL - TAB 160MG",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "APO-SOTALOL - TAB 160MG",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25646,
    "drug": {
      "current_status": "DORMANT",
      "id": 24038,
      "drug_code": 86671,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368753,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380951",
      "brand_name": "APO-ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2017-10-12T14:31:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380951",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC03",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-26T16:08:46-05:00",
    "status": "resolved",
    "en_comments": "product is discontinued",
    "en_drug_brand_name": "APO-ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "APO-ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25649,
    "drug": {
      "current_status": "DORMANT",
      "id": 24122,
      "drug_code": 86742,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368760,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381575",
      "brand_name": "APO-ZOLMITRIPTAN RAPID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2017-10-12T14:32:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381575",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC03",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-12T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ZOLMITRIPTAN RAPID",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "APO-ZOLMITRIPTAN RAPID",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25654,
    "drug": {
      "current_status": "MARKETED",
      "id": 28264,
      "drug_code": 90416,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260255,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02419548",
      "brand_name": "TARO-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-10-12T15:25:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02419548",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AX09",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-10-12T00:00:00-04:00",
    "estimated_end_date": "2017-12-08T00:00:00-05:00",
    "actual_end_date": "2017-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:48:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-EZETIMIBE",
    "en_drug_common_name": "RAN-EZETIMIBE",
    "fr_drug_brand_name": "RAN-EZETIMIBE",
    "fr_drug_common_name": "RAN-EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25658,
    "drug": {
      "current_status": "MARKETED",
      "id": 718,
      "drug_code": 11624,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251554,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251553,
          "ingredient": {
            "id": 466,
            "ingredient_code": 2322,
            "en_name": "DOPAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dopamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00761834",
      "brand_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72439",
      "number_of_ais": "2",
      "ai_group_no": "0217918002"
    },
    "created_date": "2017-10-12T15:51:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00761834",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C01CA04",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2017-10-12T00:00:00-04:00",
    "estimated_end_date": "2018-02-06T00:00:00-05:00",
    "actual_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2018-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-07T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Shortage is resolved. Returned to normal supply.",
    "fr_comments": "La pénurie est résolue. Retourné à l'approvisionnement normal.",
    "en_drug_brand_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
    "en_drug_common_name": "DOPAMINE HCL 3.2MG/ML",
    "fr_drug_brand_name": "DOPAMINE HCL 3.2MG/ML",
    "fr_drug_common_name": "DOPAMINE HCL 3.2MG/ML",
    "en_ingredients": "DEXTROSE\r\nDOPAMINE HYDROCHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorhydrate de dopamine",
    "drug_strength": "50MG\r\n3.2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25661,
    "drug": {
      "current_status": "MARKETED",
      "id": 962,
      "drug_code": 12256,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251604,
          "ingredient": {
            "id": 466,
            "ingredient_code": 2322,
            "en_name": "DOPAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dopamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251603,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00761850",
      "brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73323",
      "number_of_ais": "2",
      "ai_group_no": "0217918001"
    },
    "created_date": "2017-10-12T15:53:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00761850",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C01CA04",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2017-10-12T00:00:00-04:00",
    "estimated_end_date": "2018-03-01T00:00:00-05:00",
    "actual_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2018-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T15:09:58-05:00",
    "status": "resolved",
    "en_comments": "Supply available, allocated based on historical monthly usage. \r\nPlease review important notice regarding Dopamine on Baxter.ca: http://www.baxter.ca/en/products-expertise/product-safety-information/important-product-updates.page \r\nContact your local Baxter representative with questions.",
    "fr_comments": "L'approvisionnement disponible. Les quantités allouées sont calculées à partir de la consommation mensuelle historique. \r\nVeuillez lire un avis important concernant le Dopamine sur notre site web, Baxter.ca/fr/ : http://www.baxter.ca/fr/products-expertise/product-safety-information/important-product-updates.page . \r\nSi vous avez des questions veuillez communiquer avec votre chef de territoire de Baxter.",
    "en_drug_brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
    "en_drug_common_name": "DOPAMINE 0.8MG/ML",
    "fr_drug_brand_name": "DOPAMINE 0.8MG/ML",
    "fr_drug_common_name": "DOPAMINE 0.8MG/ML",
    "en_ingredients": "DOPAMINE HYDROCHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorhydrate de dopamine\r\nDextrose",
    "drug_strength": ".8MG\r\n50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25684,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27922,
      "drug_code": 90119,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8354009,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02416603",
      "brand_name": "GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660005"
    },
    "created_date": "2017-10-12T16:24:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416603",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06DA04",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "actual_start_date": "2017-10-11T00:00:00-04:00",
    "actual_end_date": "2018-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE ER",
    "fr_drug_brand_name": "GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE ER",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25689,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18938,
      "drug_code": 80201,
      "updated_date": "2025-05-15T04:14:07-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346128,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316528",
      "brand_name": "PRO-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2017-10-12T16:28:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316528",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-10-11T00:00:00-04:00",
    "actual_end_date": "2017-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-25T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-SOTALOL",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "PRO-SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25692,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2188,
      "drug_code": 14595,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293803,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8293802,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8293801,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02028174",
      "brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "76249",
      "number_of_ais": "3",
      "ai_group_no": "0311391002"
    },
    "created_date": "2017-10-12T16:43:52-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02028174",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AJ06",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2017-10-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO REMAINING SUPPLY - PRODUCT DISCONTINUED",
    "fr_supply_disruption_mitigation": "AUCUN STOCK DISPONIBLE",
    "en_discontinuation_comments": "PRODUCT DISCONTINUED",
    "fr_discontinuation_comments": "PRODUIT DISCONTINUé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-13T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
    "en_drug_common_name": "ACETA COD",
    "fr_drug_brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
    "fr_drug_common_name": "ACETA COD",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n8MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25698,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2190,
      "drug_code": 14596,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293806,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8293805,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8293804,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02025337",
      "brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "76250",
      "number_of_ais": "3",
      "ai_group_no": "0311391002"
    },
    "created_date": "2017-10-12T16:56:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02025337",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AJ06",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2017-10-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO SUPPLY LEFT",
    "fr_supply_disruption_mitigation": "AUCUN STOCK DISPONIBLE",
    "en_discontinuation_comments": "PRODUCT DISCONTINUED",
    "fr_discontinuation_comments": "PRODUIT DISCONTINUé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-13T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
    "en_drug_common_name": "ACETA COD",
    "fr_drug_brand_name": "ACETAMINOPHEN, CAFFEINE & CODEINE",
    "fr_drug_common_name": "ACETA COD",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n8MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25702,
    "drug": {
      "current_status": "DORMANT",
      "id": 21728,
      "drug_code": 84098,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368480,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355787",
      "brand_name": "PMS-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863008"
    },
    "created_date": "2017-10-12T17:00:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02355787",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08DB01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2017-10-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO SUPPLY",
    "fr_supply_disruption_mitigation": "PAS DE STOCK DISPONIBLE",
    "en_discontinuation_comments": "IN DEACTIVATION PROCESS",
    "fr_discontinuation_comments": "PRODUIT EN PROCESSUS DE DéSACTIVATION",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-16T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "PMS-DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25709,
    "drug": {
      "current_status": "DORMANT",
      "id": 19432,
      "drug_code": 80726,
      "updated_date": "2025-12-03T02:32:25-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368247,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02321858",
      "brand_name": "TARO-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2017-10-12T17:36:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02321858",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C08CA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2018-07-24T00:00:00-04:00",
    "estimated_end_date": "2018-07-24T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T16:19:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-AMLODIPINE",
    "en_drug_common_name": "RAN-AMLODIPINE",
    "fr_drug_brand_name": "RAN-AMLODIPINE",
    "fr_drug_common_name": "RAN-AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "Amlodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25712,
    "drug": {
      "current_status": "MARKETED",
      "id": 26406,
      "drug_code": 88747,
      "updated_date": "2025-05-15T02:33:50-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259535,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402629",
      "brand_name": "TARO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666004"
    },
    "created_date": "2017-10-12T17:42:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402629",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A02BC03",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-11-22T00:00:00-05:00",
    "actual_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:43:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-LANSOPRAZOLE",
    "en_drug_common_name": "RAN-LANSOPRAZOLE",
    "fr_drug_brand_name": "RAN-LANSOPRAZOLE",
    "fr_drug_common_name": "RAN-LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25717,
    "drug": {
      "current_status": "DORMANT",
      "id": 12784,
      "drug_code": 71743,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367615,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247493",
      "brand_name": "PMS-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101944002"
    },
    "created_date": "2017-10-12T17:46:26-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247493",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "discontinuation_date": "2017-05-30T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "in deactivation process",
    "fr_discontinuation_comments": "en processus de discontinuation",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-12T17:47:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE",
    "fr_drug_brand_name": "PMS-FUROSEMIDE",
    "fr_drug_common_name": "FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25720,
    "drug": {
      "current_status": "DORMANT",
      "id": 29756,
      "drug_code": 91762,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369230,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369229,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02433222",
      "brand_name": "TELMISARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2017-10-12T17:49:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02433222",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09DA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2017-10-16T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO REMAINING SUPPLY",
    "fr_supply_disruption_mitigation": "PAS DE STOCK DISPONIBLE",
    "en_discontinuation_comments": "IN DEACTIVATION PROCESS",
    "fr_discontinuation_comments": "EN PROCESSUS DE DISCONTINUATION",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TELMISARTAN-HCTZ",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "TELMISARTAN-HCTZ",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "25MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25724,
    "drug": {
      "current_status": "DORMANT",
      "id": 29754,
      "drug_code": 91761,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369228,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369227,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02433214",
      "brand_name": "TELMISARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783001"
    },
    "created_date": "2017-10-12T17:51:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02433214",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09DA07",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2017-10-16T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO REMAINING SUPPLY",
    "fr_supply_disruption_mitigation": "AUCUN STOCK DISPONIBLE",
    "en_discontinuation_comments": "IN DEACTIVATION PROCESS",
    "fr_discontinuation_comments": "EN PROCESSUS DE DISCONTINUATION",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TELMISARTAN-HCTZ",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "TELMISARTAN-HCTZ",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "12.5MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25727,
    "drug": {
      "current_status": "DORMANT",
      "id": 2174,
      "drug_code": 14588,
      "updated_date": "2025-12-03T02:32:15-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366840,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02048701",
      "brand_name": "PMS-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76239",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2017-10-12T17:54:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02048701",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AE01",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-03-15T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T14:10:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CLONAZEPAM TAB 0.5MG",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "PMS-CLONAZEPAM TAB 0.5MG",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25731,
    "drug": {
      "current_status": "MARKETED",
      "id": 634,
      "drug_code": 11384,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251525,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251524,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00816027",
      "brand_name": "PMS-ACETAMINOPHEN WITH CODEINE ELIXIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72052",
      "number_of_ais": "2",
      "ai_group_no": "0211376002"
    },
    "created_date": "2017-10-12T17:58:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00816027",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02BE51",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2017-11-15T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-08T20:18:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ACETAMINOPHEN W CODEINE ELIXIR",
    "en_drug_common_name": "ACET CODEINE",
    "fr_drug_brand_name": "PMS-ACETAMINOPHEN W CODEINE ELIXIR",
    "fr_drug_common_name": "ACET CODEINE",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine",
    "drug_strength": "160MG\r\n8MG",
    "drug_dosage_form": "ELIXIR",
    "drug_dosage_form_fr": "Élixir",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25734,
    "drug": {
      "current_status": "MARKETED",
      "id": 16166,
      "drug_code": 76957,
      "updated_date": "2025-12-03T00:31:09-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255767,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284006",
      "brand_name": "PMS-ALENDRONATE-FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-10-12T17:58:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284006",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA04",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-04-02T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T13:59:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ALENDRONATE-FC",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "PMS-ALENDRONATE-FC",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ACIDE ALENDRONIQUE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25740,
    "drug": {
      "current_status": "MARKETED",
      "id": 2368,
      "drug_code": 15547,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252040,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02063735",
      "brand_name": "PMS-BACLOFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77242",
      "number_of_ais": "1",
      "ai_group_no": "0113246001"
    },
    "created_date": "2017-10-12T18:00:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02063735",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M03BX01",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "estimated_end_date": "2018-01-09T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-26T15:57:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-BACLOFEN",
    "en_drug_common_name": "BACLOFEN",
    "fr_drug_brand_name": "PMS-BACLOFEN",
    "fr_drug_common_name": "BACLOFEN",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25743,
    "drug": {
      "current_status": "MARKETED",
      "id": 25152,
      "drug_code": 87655,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259112,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391198",
      "brand_name": "PMS-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2017-10-12T18:03:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391198",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2018-04-13T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T13:14:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "PMS-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25746,
    "drug": {
      "current_status": "MARKETED",
      "id": 25154,
      "drug_code": 87656,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259113,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391201",
      "brand_name": "PMS-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2017-10-12T18:03:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391201",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA06",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2018-01-26T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-17T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CANDESARTAN",
    "en_drug_common_name": "PMS-CANDESARTAN",
    "fr_drug_brand_name": "PMS-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25749,
    "drug": {
      "current_status": "MARKETED",
      "id": 14940,
      "drug_code": 75346,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255346,
          "ingredient": {
            "id": 824,
            "ingredient_code": 1840,
            "en_name": "DOMPERIDONE",
            "fr_name": "Dompéridone (Maléate de dompéridone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02268078",
      "brand_name": "TARO-DOMPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116957001"
    },
    "created_date": "2017-10-12T18:08:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02268078",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A03FA03",
    "atc_description": "PROPULSIVES",
    "anticipated_start_date": "2017-10-12T00:00:00-04:00",
    "actual_start_date": "2018-10-29T00:00:00-04:00",
    "actual_end_date": "2018-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-15T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-DOMPERIDONE",
    "en_drug_common_name": "RAN-DOMPERIDONE",
    "fr_drug_brand_name": "RAN-DOMPERIDONE",
    "fr_drug_common_name": "RAN-DOMPERIDONE",
    "en_ingredients": "DOMPERIDONE",
    "fr_ingredients": "DOMPERIDONE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25753,
    "drug": {
      "current_status": "DORMANT",
      "id": 21688,
      "drug_code": 84068,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368473,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355450",
      "brand_name": "PMS-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2017-10-12T18:19:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355450",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M01AH01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-03-19T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-22T13:06:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "PMS-CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25764,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20820,
      "drug_code": 82690,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348229,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341387",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302014"
    },
    "created_date": "2017-10-12T18:21:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341387",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL MTX",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25767,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20822,
      "drug_code": 82691,
      "updated_date": "2025-12-03T01:27:20-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348230,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341395",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2017-10-12T18:22:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341395",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25770,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20824,
      "drug_code": 82692,
      "updated_date": "2025-05-15T04:15:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348231,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02341409",
      "brand_name": "PMS-FENTANYL MTX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302013"
    },
    "created_date": "2017-10-12T18:23:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341409",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AB03",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-FENTANYL MTX",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "PMS-FENTANYL MTX",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "75MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25773,
    "drug": {
      "current_status": "MARKETED",
      "id": 11132,
      "drug_code": 67358,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254182,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243448",
      "brand_name": "PMS-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-10-12T18:24:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243448",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-01-29T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-12T19:34:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "PMS-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25776,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25952,
      "drug_code": 88334,
      "updated_date": "2025-12-03T01:30:52-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352500,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398397",
      "brand_name": "PMS-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660005"
    },
    "created_date": "2017-10-12T18:25:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398397",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DA04",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2018-04-06T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T13:41:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE ER",
    "fr_drug_brand_name": "PMS-GALANTAMINE ER",
    "fr_drug_common_name": "GALANTAMINE ER",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTAMINE",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25780,
    "drug": {
      "current_status": "MARKETED",
      "id": 12754,
      "drug_code": 71631,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254659,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247386",
      "brand_name": "PMS-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048002"
    },
    "created_date": "2017-10-12T18:26:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247386",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C03AA03",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "PMS-HYDROCHLOROTHIAZIDE",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25783,
    "drug": {
      "current_status": "MARKETED",
      "id": 7620,
      "drug_code": 50442,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253356,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231135",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643003"
    },
    "created_date": "2017-10-12T18:27:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231135",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB01",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2017-10-17T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-26T15:01:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "IPRATROPIUM",
    "fr_drug_brand_name": "PMS-IPRATROPIUM",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "125MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25787,
    "drug": {
      "current_status": "DORMANT",
      "id": 5784,
      "drug_code": 38260,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367182,
          "ingredient": {
            "id": 674,
            "ingredient_code": 2395,
            "en_name": "LACTULOSE",
            "fr_name": "Lactulose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "667",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00703486",
      "brand_name": "PMS-LACTULOSE SYR 667MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "K0863",
      "number_of_ais": "1",
      "ai_group_no": "0113020001"
    },
    "created_date": "2017-10-12T18:29:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703486",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AD11",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2017-11-07T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T19:09:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "en_drug_common_name": "LACTULOSE",
    "fr_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "fr_drug_common_name": "LACTULOSE",
    "en_ingredients": "LACTULOSE",
    "fr_ingredients": "Lactulose",
    "drug_strength": "667MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "15mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25790,
    "drug": {
      "current_status": "MARKETED",
      "id": 18204,
      "drug_code": 79471,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256388,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309114",
      "brand_name": "PMS-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2017-10-12T18:30:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309114",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L02BG04",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-19T19:02:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LETROZOLE",
    "en_drug_common_name": "LETROZOLE",
    "fr_drug_brand_name": "PMS-LETROZOLE",
    "fr_drug_common_name": "LETROZOLE",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25793,
    "drug": {
      "current_status": "MARKETED",
      "id": 19378,
      "drug_code": 80653,
      "updated_date": "2025-05-15T02:32:19-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256771,
          "ingredient": {
            "id": 3178,
            "ingredient_code": 13366,
            "en_name": "MEMANTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mémantine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02321130",
      "brand_name": "PMS-MEMANTINE",
      "brand_name_fr": "PMS-MÉMANTINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150423001"
    },
    "created_date": "2017-10-12T18:33:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02321130",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06DX01",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2018-03-26T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-24T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-MEMANTINE",
    "en_drug_common_name": "MEMANTINE",
    "fr_drug_brand_name": "PMS-MEMANTINE",
    "fr_drug_common_name": "MEMANTINE",
    "en_ingredients": "MEMANTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mémantine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25796,
    "drug": {
      "current_status": "DORMANT",
      "id": 10688,
      "drug_code": 66363,
      "updated_date": "2025-05-15T06:55:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367455,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242589",
      "brand_name": "PMS-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773002"
    },
    "created_date": "2017-10-12T18:34:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242589",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A10BA02",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2018-01-15T00:00:00-05:00",
    "estimated_end_date": "2018-03-07T00:00:00-05:00",
    "actual_start_date": "2018-01-24T00:00:00-05:00",
    "actual_end_date": "2018-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-22T13:17:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-METFORMIN",
    "en_drug_common_name": "METFORMIN",
    "fr_drug_brand_name": "PMS-METFORMIN",
    "fr_drug_common_name": "METFORMIN",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "850MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25801,
    "drug": {
      "current_status": "MARKETED",
      "id": 17164,
      "drug_code": 78192,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256059,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02296608",
      "brand_name": "PMS-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2017-10-12T19:50:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296608",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "PMS-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25804,
    "drug": {
      "current_status": "MARKETED",
      "id": 20798,
      "drug_code": 82615,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257356,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02340577",
      "brand_name": "PMS-QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206003"
    },
    "created_date": "2017-10-12T19:52:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02340577",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA06",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2019-09-20T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2019-10-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-10-30T20:37:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "PMS-QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRILE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25807,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15030,
      "drug_code": 75465,
      "updated_date": "2025-12-03T01:23:44-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341406,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269279",
      "brand_name": "PMS-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2017-10-12T19:53:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269279",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA01",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T21:16:08-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469995)",
    "fr_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469995)",
    "en_drug_brand_name": "PMS-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "PMS-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25810,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3484,
      "drug_code": 18776,
      "updated_date": "2025-05-15T03:45:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8301641,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02006758",
      "brand_name": "SOFLAX SYRUP 4MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81050",
      "number_of_ais": "1",
      "ai_group_no": "0104351003"
    },
    "created_date": "2017-10-12T19:54:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02006758",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA02",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-19T15:27:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SOFLAX SYRUP 4MG/ML",
    "en_drug_common_name": "SOFLAX",
    "fr_drug_brand_name": "SOFLAX SYRUP 4MG/ML",
    "fr_drug_common_name": "SOFLAX",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "4MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25813,
    "drug": {
      "current_status": "MARKETED",
      "id": 2114,
      "drug_code": 14487,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251968,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01994344",
      "brand_name": "SOFLAX CAPSULES 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76120",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2017-10-12T19:55:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01994344",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA02",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T20:37:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SOFLAX CAPSULES 100MG",
    "en_drug_common_name": "SOFLAX",
    "fr_drug_brand_name": "SOFLAX CAPSULES 100MG",
    "fr_drug_common_name": "SOFLAX",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25816,
    "drug": {
      "current_status": "MARKETED",
      "id": 14124,
      "drug_code": 74163,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255100,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02256428",
      "brand_name": "PMS-SUMATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238007"
    },
    "created_date": "2017-10-12T19:56:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256428",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC01",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2017-11-06T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-08T20:25:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SUMATRIPTAN",
    "en_drug_common_name": "SUMATRIPTAN",
    "fr_drug_brand_name": "PMS-SUMATRIPTAN",
    "fr_drug_common_name": "SUMATRIPTAN",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTANE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25819,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8882,
      "drug_code": 61148,
      "updated_date": "2025-12-03T01:17:12-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8325573,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237791",
      "brand_name": "PMS-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846003"
    },
    "created_date": "2017-10-12T19:57:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237791",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08DA01",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2017-11-02T00:00:00-04:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T19:16:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "PMS-VERAPAMIL SR",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25823,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19602,
      "drug_code": 80970,
      "updated_date": "2025-12-03T01:26:33-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8346892,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324229",
      "brand_name": "PMS-ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2017-10-12T19:58:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324229",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC03",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2017-11-06T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-08T20:27:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "PMS-ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25826,
    "drug": {
      "current_status": "DORMANT",
      "id": 20152,
      "drug_code": 81599,
      "updated_date": "2025-12-03T02:32:26-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368345,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330237",
      "brand_name": "PMS-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2017-10-12T19:59:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330237",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N07CA01",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T19:17:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE",
    "fr_drug_brand_name": "PMS-BETAHISTINE",
    "fr_drug_common_name": "BETAHISTINE",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25829,
    "drug": {
      "current_status": "DORMANT",
      "id": 31976,
      "drug_code": 94550,
      "updated_date": "2025-12-03T02:32:40-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369425,
          "ingredient": {
            "id": 1582,
            "ingredient_code": 122,
            "en_name": "LAMIVUDINE",
            "fr_name": "Lamivudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369424,
          "ingredient": {
            "id": 2704,
            "ingredient_code": 11893,
            "en_name": "ABACAVIR",
            "fr_name": "Abacavir (Sulfate d'abacavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458381",
      "brand_name": "PMS-ABACAVIR-LAMIVUDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251241001"
    },
    "created_date": "2017-10-12T20:00:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458381",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J05AR02",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2017-10-01T00:00:00-04:00",
    "actual_end_date": "2018-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-03T20:17:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ABACAVIR-LAMIVUDINE",
    "en_drug_common_name": "ABACAVIR/LAMIVUDINE",
    "fr_drug_brand_name": "PMS-ABACAVIR-LAMIVUDINE",
    "fr_drug_common_name": "ABACAVIR-LAMIVUDINE",
    "en_ingredients": "ABACAVIR\r\nLAMIVUDINE",
    "fr_ingredients": "Lamivudine",
    "drug_strength": "600MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 25856,
    "drug": {
      "current_status": "MARKETED",
      "id": 21478,
      "drug_code": 83854,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257671,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353342",
      "brand_name": "LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2017-10-13T11:52:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353342",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-10-20T00:00:00-04:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2017-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-10T15:19:32-05:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM COMPRIMES",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25863,
    "drug": {
      "current_status": "MARKETED",
      "id": 12910,
      "drug_code": 72060,
      "updated_date": "2025-05-15T02:31:27-04:00",
      "company": {
        "id": 190,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 5181,
        "mfr_code": "SRO08",
        "name": "EMD SERONO, A DIVISION OF EMD INC., CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2695 NORTH SHERIDAN WAY, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5K 2N6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254730,
          "ingredient": {
            "id": 3060,
            "ingredient_code": 13224,
            "en_name": "CETRORELIX",
            "fr_name": "Cétrorélix (Acétate de cétrorélix)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02247766",
      "brand_name": "CETROTIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149341001"
    },
    "created_date": "2017-10-13T12:47:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247766",
    "company_name": "EMD SERONO A DIVISION OF EMD INC CANADA",
    "atc_number": "H01CC02",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "estimated_end_date": "2017-12-31T00:00:00-05:00",
    "actual_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CETROTIDE",
    "en_drug_common_name": "cetrorelix acetate",
    "fr_drug_brand_name": "CETROTIDE",
    "fr_drug_common_name": "cetrorelix acetate",
    "en_ingredients": "CETRORELIX",
    "fr_ingredients": "CETRORELIX",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "1 vial / flacon",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25869,
    "drug": {
      "current_status": "MARKETED",
      "id": 15716,
      "drug_code": 76426,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255619,
          "ingredient": {
            "id": 3284,
            "ingredient_code": 918,
            "en_name": "MIDODRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de midodrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278685",
      "brand_name": "APO-MIDODRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123066002"
    },
    "created_date": "2017-10-13T13:01:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278685",
    "company_name": "AA PHARMA INC",
    "atc_number": "C01CA17",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2018-12-17T00:00:00-05:00",
    "actual_start_date": "2018-07-26T00:00:00-04:00",
    "actual_end_date": "2018-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-18T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Midodrine 2.5mg is available",
    "fr_comments": "Midodrine 2.5mg est disponible",
    "en_drug_brand_name": "MIDODRINE",
    "en_drug_common_name": "MIDODRINE",
    "fr_drug_brand_name": "MIDODRINE",
    "fr_drug_common_name": "MIDODRINE",
    "en_ingredients": "MIDODRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de midodrine",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25885,
    "drug": {
      "current_status": "MARKETED",
      "id": 18238,
      "drug_code": 79506,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8256398,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309467",
      "brand_name": "MYLAN-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435002"
    },
    "created_date": "2017-10-13T13:59:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309467",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2017-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-21T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "MYLAN-ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25895,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26588,
      "drug_code": 88898,
      "updated_date": "2025-05-15T04:21:05-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352942,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02404192",
      "brand_name": "MYLAN-TOLTERODINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2017-10-13T14:23:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404192",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BD07",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "hc_updated_date": "2022-02-15T14:22:16-05:00",
    "anticipated_start_date": "2017-11-16T00:00:00-05:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2022-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-15T14:22:19-05:00",
    "status": "resolved",
    "en_comments": "Last lot 3082332, Expiry November-30-2018",
    "en_drug_brand_name": "MYLAN-TOLTERODINE ER",
    "en_drug_common_name": "TOLTERODINE ER",
    "fr_drug_brand_name": "MYLAN-TOLTERODINE ER",
    "fr_drug_common_name": "TOLTERODINE ER",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT, 100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25898,
    "drug": {
      "current_status": "MARKETED",
      "id": 25350,
      "drug_code": 87821,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259190,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392941",
      "brand_name": "MYLAN-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2017-10-13T14:26:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392941",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2018-10-15T00:00:00-04:00",
    "estimated_end_date": "2018-10-19T00:00:00-04:00",
    "actual_end_date": "2018-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-16T11:22:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "MYLAN-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25921,
    "drug": {
      "current_status": "MARKETED",
      "id": 9576,
      "drug_code": 63199,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253709,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239717",
      "brand_name": "NEURONTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929004"
    },
    "created_date": "2017-10-13T15:13:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239717",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N03AX12",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-12-29T00:00:00-05:00",
    "actual_end_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-01T14:39:15-05:00",
    "status": "resolved",
    "en_comments": "Please note that only 1 lot with an expiry date of 3/31/2018 remains available.",
    "fr_comments": "Prendre note que seulement 1 lot est disponible avec la date d'expiration du 31 mars 2018.",
    "en_drug_brand_name": "NEURONTIN 600MG",
    "en_drug_common_name": "NEURONTIN",
    "fr_drug_brand_name": "NEURONTIN 600MG",
    "fr_drug_common_name": "NEURONTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 25930,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6242,
      "drug_code": 43041,
      "updated_date": "2025-05-15T03:49:42-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8312750,
          "ingredient": {
            "id": 2128,
            "ingredient_code": 11085,
            "en_name": "DOBUTAMINE",
            "fr_name": "Dobutamine (Chlorhydrate de dobutamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02210401",
      "brand_name": "DOBUTAMINE INJECTION USP",
      "brand_name_fr": "DOBUTAMINE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9321",
      "number_of_ais": "1",
      "ai_group_no": "0112000001"
    },
    "created_date": "2017-10-13T16:49:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02210401",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C01CA07",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2018-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-08T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DOBUTAMINE INJECTION USP",
    "en_drug_common_name": "DOBUTAMINE",
    "fr_drug_brand_name": "DOBUTAMINE INJECTION USP",
    "fr_drug_common_name": "DOBUTAMINE",
    "en_ingredients": "DOBUTAMINE",
    "fr_ingredients": "DOBUTAMINE",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26008,
    "drug": {
      "current_status": "MARKETED",
      "id": 15012,
      "drug_code": 75447,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255374,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "48",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269074",
      "brand_name": "LIPIDIL EZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895005"
    },
    "created_date": "2017-10-16T15:32:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269074",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C10AB05",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-10-26T00:00:00-04:00",
    "actual_end_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-07T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LIPIDIL EZ",
    "en_drug_common_name": "LIPIDIL EZ",
    "fr_drug_brand_name": "LIPIDIL EZ",
    "fr_drug_common_name": "LIPIDIL EZ",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "48MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26035,
    "drug": {
      "current_status": "MARKETED",
      "id": 20476,
      "drug_code": 82129,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257254,
          "ingredient": {
            "id": 1162,
            "ingredient_code": 6731,
            "en_name": "DIGOXIN",
            "fr_name": "Digoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.0625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02335700",
      "brand_name": "PMS-DIGOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107281004"
    },
    "created_date": "2017-10-16T18:37:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02335700",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "C01AA05",
    "atc_description": "CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2017-11-24T00:00:00-05:00",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-11-24T00:00:00-05:00",
    "actual_end_date": "2017-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-21T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TOLOXIN",
    "en_drug_common_name": "TOLOXIN 0.0625mg TABS 250",
    "fr_drug_brand_name": "TOLOXIN",
    "fr_drug_common_name": "TOLOXIN 0.0625mg TABS 250",
    "en_ingredients": "DIGOXIN",
    "fr_ingredients": "Digoxine",
    "drug_strength": "0.0625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26046,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8536,
      "drug_code": 60040,
      "updated_date": "2025-05-15T03:56:02-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8324142,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236753",
      "brand_name": "FLUVOXAMINE-50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2017-10-16T18:39:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236753",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06AB08",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-14T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUVOXAMINE-50",
    "en_drug_common_name": "FLUVOXAMINE",
    "fr_drug_brand_name": "FLUVOXAMINE 50MG",
    "fr_drug_common_name": "FLUVOXAMINE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26063,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 31548,
      "drug_code": 93867,
      "updated_date": "2025-05-15T04:24:27-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8356590,
          "ingredient": {
            "id": 4148,
            "ingredient_code": 22694,
            "en_name": "ASUNAPREVIR",
            "fr_name": "Asunaprévir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452294",
      "brand_name": "SUNVEPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157870001"
    },
    "created_date": "2017-10-16T19:07:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02452294",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AE15",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SUNVEPRA",
    "en_drug_common_name": "Asunaprevir",
    "fr_drug_brand_name": "Sunvepra",
    "fr_drug_common_name": "Asunaprévir",
    "en_ingredients": "ASUNAPREVIR",
    "fr_ingredients": "Asunaprévir",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 56",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26076,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17810,
      "drug_code": 78867,
      "updated_date": "2025-05-15T04:13:14-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344844,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303345",
      "brand_name": "RIVA-FLUVOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2017-10-16T19:45:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303345",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "N06AB08",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-10-16T00:00:00-04:00",
    "estimated_end_date": "2017-10-27T00:00:00-04:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2017-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-01T14:23:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-FLUVOX",
    "en_drug_common_name": "Fluvoxamine 50mg",
    "fr_drug_brand_name": "Riva-Fluvox",
    "fr_drug_common_name": "Fluvoxamine 50mg",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26079,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17812,
      "drug_code": 78869,
      "updated_date": "2025-05-15T04:13:14-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344846,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303361",
      "brand_name": "RIVA-FLUVOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450001"
    },
    "created_date": "2017-10-16T19:47:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303361",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "N06AB08",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-10-16T00:00:00-04:00",
    "estimated_end_date": "2017-10-27T00:00:00-04:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-01T14:26:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-FLUVOX",
    "en_drug_common_name": "Fluvoxamine 100mg",
    "fr_drug_brand_name": "Riva-Fluvox",
    "fr_drug_common_name": "fluvoxamine 100mg",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26084,
    "drug": {
      "current_status": "MARKETED",
      "id": 2566,
      "drug_code": 16162,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252090,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8252089,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976184",
      "brand_name": "SENSORCAINE WITH EPINEPHRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77948",
      "number_of_ais": "2",
      "ai_group_no": "0204884001"
    },
    "created_date": "2017-10-16T20:25:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976184",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB51",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-10-20T00:00:00-04:00",
    "estimated_end_date": "2018-02-23T00:00:00-05:00",
    "actual_end_date": "2018-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-02-22T06:00:06-05:00",
    "status": "resolved",
    "en_comments": "Delay in releasing the product",
    "fr_comments": "Retard dans le relachement du produit.",
    "en_drug_brand_name": "SENSORCAINE WITH EPINEPHRINE",
    "en_drug_common_name": "Sensorcaine® 0.25% w/epi1:200M, 10x20mL SU Vial",
    "fr_drug_brand_name": "SENSORCAINE AVEC EPINEPHRINE",
    "fr_drug_common_name": "Sensorcaine® 0.25% avec epi1:200M, 10x20mL SU Fiole",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nÉpinéphrine",
    "drug_strength": "2.5MG\r\n5MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26087,
    "drug": {
      "current_status": "MARKETED",
      "id": 8440,
      "drug_code": 589,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250161,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250160,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001791",
      "brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23890",
      "number_of_ais": "2",
      "ai_group_no": "0201284001"
    },
    "created_date": "2017-10-16T20:58:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001791",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB52",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-10-27T00:00:00-04:00",
    "estimated_end_date": "2018-02-19T00:00:00-05:00",
    "actual_end_date": "2018-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-02-27T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Delay in releasing the drug.",
    "en_drug_brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
    "en_drug_common_name": "Xylocaine® 1% w/epi.1:100M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine",
    "fr_drug_common_name": "Xylocaine® 1% avec epi.1:100M 10x20mL MD Fiole",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "10MG\r\n0.01MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26118,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2017-10-17T13:18:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA03",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2018-01-04T00:00:00-05:00",
    "estimated_end_date": "2018-11-27T00:00:00-05:00",
    "actual_start_date": "2018-01-04T00:00:00-05:00",
    "actual_end_date": "2018-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-28T00:50:49-05:00",
    "status": "resolved",
    "en_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. Baxter’s 250 mL and 500 mL 5% Dextrose Solution, VIAFLEX Containers are available as alternate product.",
    "fr_comments": "Si vous avez d’autres questions au sujet de ce produit, veuillez communiquer avec le Service à la clientèle de Baxter au 1 888 719-9955 ou avec le Service d’information médicale de Baxter au 1 855 584-1368. Les contenants VIAFLEX de 250 ml et 500 ml de solution de dextrose à 5 % de Baxter sont offerts en guise de produit de remplacement.",
    "en_drug_brand_name": "DEXTROSE 5% INJ 5GM/100ML USP",
    "en_drug_common_name": "Dextrose 5% Inj - AVIVA",
    "fr_drug_brand_name": "5% Dextrose Inj - AVIVA",
    "fr_drug_common_name": "5% Dextrose Inj - AVIVA",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL AVIVA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26121,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2017-10-17T13:19:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA03",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2018-01-04T00:00:00-05:00",
    "estimated_end_date": "2018-11-27T00:00:00-05:00",
    "actual_start_date": "2018-01-04T00:00:00-05:00",
    "actual_end_date": "2018-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-28T00:49:44-05:00",
    "status": "resolved",
    "en_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. Baxter’s 250 mL and 500 mL 0.9% Sodium Chloride Solution, VIAFLEX Containers are available as alternate product.",
    "fr_comments": "Si vous avez d’autres questions au sujet de ce produit, veuillez communiquer avec le Service à la clientèle de Baxter au 1 888 719-9955 ou avec le Service d’information médicale de Baxter au 1 855 584-1368. Les contenants VIAFLEX de 250 ml et 500 ml de solution de chlorure de sodium à 0,9 % de Baxter sont offerts en guise de produit de remplacement.",
    "en_drug_brand_name": "SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP",
    "en_drug_common_name": "0.9% Sodium Chloride Inj - AVIVA",
    "fr_drug_brand_name": "0.9% Sodium Chloride Inj - AVIVA",
    "fr_drug_common_name": "0.9% Sodium Chloride Inj - AVIVA",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL AVIVA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26124,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28722,
      "drug_code": 90846,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354578,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423766",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/ML; 15MG/3ML; 50MG/10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2017-10-17T14:20:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423766",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD08",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2018-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T02:45:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5 x 10ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26143,
    "drug": {
      "current_status": "MARKETED",
      "id": 28796,
      "drug_code": 90909,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260448,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424398",
      "brand_name": "CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2017-10-17T16:33:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424398",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "M01AH01",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "actual_start_date": "2017-10-17T00:00:00-04:00",
    "actual_end_date": "2017-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-29T17:00:45-05:00",
    "status": "resolved",
    "en_comments": "100's bottle is on back order",
    "fr_comments": "Bouteille de 100 en rupture d'inventaire",
    "en_drug_brand_name": "CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26146,
    "drug": {
      "current_status": "MARKETED",
      "id": 18642,
      "drug_code": 79915,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256525,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313650",
      "brand_name": "PRO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938001"
    },
    "created_date": "2017-10-17T16:34:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313650",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-10-17T00:00:00-04:00",
    "actual_end_date": "2017-11-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-08T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "PRO-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26154,
    "drug": {
      "current_status": "MARKETED",
      "id": 14114,
      "drug_code": 74140,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255095,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256177",
      "brand_name": "APO-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418002"
    },
    "created_date": "2017-10-17T18:26:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256177",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB07",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2017-12-14T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-04T19:33:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "APO-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26159,
    "drug": {
      "current_status": "MARKETED",
      "id": 11788,
      "drug_code": 69269,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254376,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02245247",
      "brand_name": "APO-GLICLAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934001"
    },
    "created_date": "2017-10-17T18:29:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245247",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB09",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2018-06-22T00:00:00-04:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-22T18:17:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GLICLAZIDE",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "APO-GLICLAZIDE",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26163,
    "drug": {
      "current_status": "MARKETED",
      "id": 22470,
      "drug_code": 84906,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258069,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364123",
      "brand_name": "APO-HYDROMORPHONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698003"
    },
    "created_date": "2017-10-17T18:30:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364123",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA03",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2018-01-05T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2017-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-15T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROMORPHONE",
    "en_drug_common_name": "HYDROMORPHONE HCL",
    "fr_drug_brand_name": "APO-HYDROMORPHONE",
    "fr_drug_common_name": "HYDROMORPHONE HCL",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26166,
    "drug": {
      "current_status": "DORMANT",
      "id": 6334,
      "drug_code": 43223,
      "updated_date": "2025-12-03T02:32:17-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367207,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217511",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9550",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2017-10-17T18:35:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217511",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA03",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-26T23:23:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 20 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL TABLET 20 MG",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26182,
    "drug": {
      "current_status": "MARKETED",
      "id": 21824,
      "drug_code": 84202,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257796,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356902",
      "brand_name": "RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332003"
    },
    "created_date": "2017-10-18T12:04:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356902",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N05AX08",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-10-27T00:00:00-04:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2017-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-24T15:18:50-04:00",
    "status": "avoided_shortage",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE TAB",
    "fr_drug_brand_name": "RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE COMPRIME",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26195,
    "drug": {
      "current_status": "DORMANT",
      "id": 18668,
      "drug_code": 79944,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368175,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313928",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2017-10-18T12:28:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313928",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH04",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-25T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-13T21:07:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26211,
    "drug": {
      "current_status": "MARKETED",
      "id": 27244,
      "drug_code": 89495,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259841,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410303",
      "brand_name": "MOVISSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106372001"
    },
    "created_date": "2017-10-18T13:23:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410303",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AC01",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2018-02-15T00:00:00-05:00",
    "actual_end_date": "2018-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-09T16:51:26-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MOVISSE",
    "en_drug_common_name": "MOVISSE",
    "fr_drug_brand_name": "MOVISSE",
    "fr_drug_common_name": "MOVISSE",
    "en_ingredients": "NORETHINDRONE",
    "fr_ingredients": "Noréthindrone",
    "drug_strength": "0.35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26224,
    "drug": {
      "current_status": "MARKETED",
      "id": 17086,
      "drug_code": 78118,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256027,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295822",
      "brand_name": "APO-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2017-10-18T13:47:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295822",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB11",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-02-12T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T13:28:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "APO-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26238,
    "drug": {
      "current_status": "DORMANT",
      "id": 28852,
      "drug_code": 90964,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 1576,
        "created_date": "2017-03-09T13:24:48-05:00",
        "updated_date": "2025-05-15T06:00:17-04:00",
        "company_code": 14461,
        "mfr_code": "",
        "name": "SEPTA PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7035 MAXWELL ROAD, UNIT # 2",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5S 1R5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369098,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424975",
      "brand_name": "SEPTA-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2017-10-18T15:23:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424975",
    "company_name": "SEPTA PHARMACEUTICALS INC",
    "atc_number": "C09CA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-11-05T00:00:00-04:00",
    "actual_start_date": "2017-10-05T00:00:00-04:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:01:04-05:00",
    "status": "resolved",
    "en_comments": "The drug shortage has been resolved",
    "fr_comments": "Resolved",
    "en_drug_brand_name": "SEPTA-LOSARTAN",
    "en_drug_common_name": "Losartan 50 mg",
    "fr_drug_brand_name": "SEPTA-LOSARTAN 50 mg",
    "fr_drug_common_name": "Losartan 50 mg",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 26243,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20898,
      "drug_code": 82854,
      "updated_date": "2025-05-15T04:16:04-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348336,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02343053",
      "brand_name": "PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2017-10-18T15:46:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02343053",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C01BC03",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2017-10-27T00:00:00-04:00",
    "estimated_end_date": "2018-03-16T00:00:00-04:00",
    "actual_start_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2018-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-08T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROPAFENONE",
    "en_drug_common_name": "PROPARENONE",
    "fr_drug_brand_name": "PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE COMPRIME",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26256,
    "drug": {
      "current_status": "MARKETED",
      "id": 12576,
      "drug_code": 71309,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254614,
          "ingredient": {
            "id": 6333,
            "ingredient_code": 1915,
            "en_name": "CYCLOSPORINE",
            "fr_name": "Cyclosporine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247074",
      "brand_name": "SANDOZ CYCLOSPORINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115996003"
    },
    "created_date": "2017-10-18T18:56:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247074",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AD01",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2017-11-15T00:00:00-05:00",
    "estimated_end_date": "2018-01-31T00:00:00-05:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-05T23:43:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CYCLOSPORINE",
    "en_drug_common_name": "CYCLOSPORINE",
    "fr_drug_brand_name": "SANDOZ CYCLOSPORINE",
    "fr_drug_common_name": "CYCLOSPORINE",
    "en_ingredients": "CYCLOSPORINE",
    "fr_ingredients": "CYCLOSPORINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26269,
    "drug": {
      "current_status": "MARKETED",
      "id": 52257,
      "drug_code": 94899,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8262338,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02461404",
      "brand_name": "FUROSEMIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101944003"
    },
    "created_date": "2017-10-18T20:16:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461404",
    "company_name": "STERIMAX INC",
    "atc_number": "C03CA01",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2018-03-05T00:00:00-05:00",
    "actual_start_date": "2017-10-18T00:00:00-04:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-03T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Product is available at wholesalers.",
    "fr_comments": "Produit est disponible chez les grossistes.",
    "en_drug_brand_name": "FUROSEMIDE INJECTION USP",
    "en_drug_common_name": "FUROSEMIDE INJECTION USP",
    "fr_drug_brand_name": "FUROSÉMIDE INJECTABLE USP",
    "fr_drug_common_name": "FUROSÉMIDE INJECTABLE USP",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "25 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26272,
    "drug": {
      "current_status": "MARKETED",
      "id": 3610,
      "drug_code": 1905,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250330,
          "ingredient": {
            "id": 800,
            "ingredient_code": 9197,
            "en_name": "SODIUM BICARBONATE",
            "fr_name": "Bicarbonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "84",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00261998",
      "brand_name": "SODIUM BICARBONATE INJECTION USP",
      "brand_name_fr": "BICARBONATE DE SODIUM INJECTABLE USP",
      "descriptor": "SINGLE-USE (SYRINGE OR VIAL)",
      "pediatric_flag": false,
      "accession_number": "45498",
      "number_of_ais": "1",
      "ai_group_no": "0104153005"
    },
    "created_date": "2017-10-18T20:41:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00261998",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA02",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2017-10-23T00:00:00-04:00",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2017-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-06T22:06:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM BICARBONATE INJECTION USP",
    "en_drug_common_name": "Sodium Bicarbonate",
    "fr_drug_brand_name": "SODIUM BICARBONATE INJECTION USP",
    "fr_drug_common_name": "SODIUM BICARBONATE",
    "en_ingredients": "SODIUM BICARBONATE",
    "fr_ingredients": "Bicarbonate de sodium",
    "drug_strength": "84MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26382,
    "drug": {
      "current_status": "MARKETED",
      "id": 13302,
      "drug_code": 72897,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254825,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248542",
      "brand_name": "REMERON RD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2017-10-19T15:48:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248542",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N06AX11",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_start_date": "2017-11-02T00:00:00-04:00",
    "actual_end_date": "2017-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-09T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "REMERON RD",
    "en_drug_common_name": "(mirtazapine) Orally Disintegrating Tablets",
    "fr_drug_brand_name": "REMERON RD",
    "fr_drug_common_name": "Comprimés à désintégration orale mirtazapine",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26385,
    "drug": {
      "current_status": "MARKETED",
      "id": 22018,
      "drug_code": 84384,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8257882,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02358808",
      "brand_name": "PRADAXA",
      "brand_name_fr": "",
      "descriptor": "KNOWN AS PRADAX",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467003"
    },
    "created_date": "2017-10-19T15:53:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02358808",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "B01AE07",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2017-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Pradaxa 150mg 6x10 Blister Pack format remains available",
    "fr_supply_disruption_mitigation": "Pradaxa 150mg 6x10 plaquette alveolee toujours disponible",
    "en_discontinuation_comments": "Pradaxa 150mg 6x10 Blister Pack format remains available",
    "fr_discontinuation_comments": "Pradaxa 150mg 6x10 plaquette alveolee toujours disponible",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-19T16:08:54-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRADAXA",
    "en_drug_common_name": "Pradaxa Bottles 60's",
    "fr_drug_brand_name": "Pradaxa",
    "fr_drug_common_name": "Pradaxa bouteilles 60's",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "Dabigatran Etexilate",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottle of 60's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26394,
    "drug": {
      "current_status": "MARKETED",
      "id": 7478,
      "drug_code": 50121,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253321,
          "ingredient": {
            "id": 2376,
            "ingredient_code": 11378,
            "en_name": "EPOPROSTENOL",
            "fr_name": "Époprosténol (Époprosténol sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02230845",
      "brand_name": "FLOLAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133040001"
    },
    "created_date": "2017-10-19T17:38:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230845",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "B01AC09",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2017-11-09T00:00:00-05:00",
    "actual_start_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2017-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-09T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour un approvisionnement d’urgence, communiquez avec le Service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "FLOLAN",
    "en_drug_common_name": "Epoprostenol Powder for Injection",
    "fr_drug_brand_name": "FLOLAN",
    "fr_drug_common_name": "époprosténol en poudre pour injection",
    "en_ingredients": "EPOPROSTENOL",
    "fr_ingredients": "époprosténol",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26397,
    "drug": {
      "current_status": "MARKETED",
      "id": 6280,
      "drug_code": 43108,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253031,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02213486",
      "brand_name": "VENTOLIN RESPIRATOR SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9401",
      "number_of_ais": "1",
      "ai_group_no": "0108887006"
    },
    "created_date": "2017-10-19T17:45:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213486",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AC02",
    "atc_description": "ADRENERGICS, INHALANTS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-29T18:36:47-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "VENTOLIN RESPIRATOR SOLUTION",
    "en_drug_common_name": "salbutamol sulfate solution",
    "fr_drug_brand_name": "Solution VENTOLIN pour respirateur",
    "fr_drug_common_name": "solution de sulfate de salbutamol",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "10ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26411,
    "drug": {
      "current_status": "MARKETED",
      "id": 2822,
      "drug_code": 16804,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 16877,
        "created_date": "2020-06-16T21:30:06-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 17770,
        "mfr_code": "",
        "name": "JUNO PHARMACEUTICALS CORP.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2233 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 2X7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252159,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02126559",
      "brand_name": "IMDUR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78738",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2017-10-20T00:33:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126559",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "C01DA14",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2017-10-19T00:00:00-04:00",
    "estimated_end_date": "2018-02-08T00:00:00-05:00",
    "actual_start_date": "2017-10-19T00:00:00-04:00",
    "actual_end_date": "2018-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-22T21:13:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMDUR - EXTENDED RELEASE TABLETS 60 MG",
    "en_drug_common_name": "isosorbide-5-mononitrate extended release tablets",
    "fr_drug_brand_name": "IMDUR- Comprimés à libération prolongée à 60 mg",
    "fr_drug_common_name": "5-mononitrate d'isosorbide en comprimés à libération prolongée",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26414,
    "drug": {
      "current_status": "MARKETED",
      "id": 2822,
      "drug_code": 16804,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 16877,
        "created_date": "2020-06-16T21:30:06-04:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 17770,
        "mfr_code": "",
        "name": "JUNO PHARMACEUTICALS CORP.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2233 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 2X7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252159,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02126559",
      "brand_name": "IMDUR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78738",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2017-10-20T00:39:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126559",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "C01DA14",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2017-10-19T00:00:00-04:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-10-19T00:00:00-04:00",
    "actual_end_date": "2017-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-12-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMDUR - EXTENDED RELEASE TABLETS 60 MG",
    "en_drug_common_name": "isosorbide-5-mononitrate extended release tablets",
    "fr_drug_brand_name": "IMDUR- Comprimés à libération prolongée à 60 mg",
    "fr_drug_common_name": "5-mononitrate d'isosorbide en comprimés à libération prolongée",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26432,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25184,
      "drug_code": 87679,
      "updated_date": "2025-05-15T04:20:25-04:00",
      "company": {
        "id": 468,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5362,
        "mfr_code": "VLH07",
        "name": "LUNDBECK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 ALFRED-NOBEL, SUITE 400",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": "",
        "contact_information": "514-844-8515  / Canada@Lundbeck.com"
      },
      "drug_ingredients": [
        {
          "id": 8351927,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391449",
      "brand_name": "CIPRALEX MELTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435002"
    },
    "created_date": "2017-10-20T13:42:59-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02391449",
    "company_name": "LUNDBECK CANADA INC",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-06-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-24T15:59:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CIPRALEX MELTZ",
    "en_drug_common_name": "Escitalopram",
    "fr_drug_brand_name": "Cipralex Meltz",
    "fr_drug_common_name": "Escitalopram",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26436,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25186,
      "drug_code": 87680,
      "updated_date": "2025-05-15T04:20:25-04:00",
      "company": {
        "id": 468,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5362,
        "mfr_code": "VLH07",
        "name": "LUNDBECK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 ALFRED-NOBEL, SUITE 400",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": "",
        "contact_information": "514-844-8515  / Canada@Lundbeck.com"
      },
      "drug_ingredients": [
        {
          "id": 8351928,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391457",
      "brand_name": "CIPRALEX MELTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2017-10-20T13:53:21-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02391457",
    "company_name": "LUNDBECK CANADA INC",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2018-06-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-07-24T15:59:02-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CIPRALEX MELTZ",
    "en_drug_common_name": "Escitalopram",
    "fr_drug_brand_name": "CIPRALEX MELTZ",
    "fr_drug_common_name": "Escitalopram",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26463,
    "drug": {
      "current_status": "MARKETED",
      "id": 29852,
      "drug_code": 91896,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260823,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434652",
      "brand_name": "ACH-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435002"
    },
    "created_date": "2017-10-20T15:11:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434652",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-25T00:00:00-04:00",
    "estimated_end_date": "2017-12-01T00:00:00-05:00",
    "actual_start_date": "2017-09-25T00:00:00-04:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T19:58:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "ACH-ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 BLISTERS PACKS/BOX (60 TABS/BOX)  |  6 PLAQUETTES ALVÉOLÉES/BOÎTE (60 COMPRIMÉS/BOÎTES)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 26466,
    "drug": {
      "current_status": "MARKETED",
      "id": 29854,
      "drug_code": 91897,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260824,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434660",
      "brand_name": "ACH-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2017-10-20T15:15:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434660",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N06AB10",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-26T00:00:00-04:00",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-09-26T00:00:00-04:00",
    "actual_end_date": "2017-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T19:52:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "ACH-ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3 BLISTER PACKS/BOX (30 TABS/BOX)  | 3 PLAQUETTES ALVÉOLÉES/BOÎTE (30 COMPRIMÉS/BOÎTES)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 26475,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 578,
      "drug_code": 11254,
      "updated_date": "2025-05-15T03:37:49-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8287718,
          "ingredient": {
            "id": 358,
            "ingredient_code": 5019,
            "en_name": "NICOTINIC ACID",
            "fr_name": "Acide nicotinique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00779806",
      "brand_name": "NIODAN 500 MG TIME RELEASE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71832",
      "number_of_ais": "1",
      "ai_group_no": "0108396003"
    },
    "created_date": "2017-10-20T18:14:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00779806",
    "company_name": "ODAN LABORATORIES LTD",
    "atc_number": "C04AC01",
    "atc_description": "PERIPHERALVASODILATORS",
    "actual_start_date": "2018-06-29T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:39-04:00",
    "status": "resolved",
    "en_comments": "product discontinued",
    "fr_comments": "produit discontinué",
    "en_drug_brand_name": "NIODAN 500 MG TIME RELEASE TABLETS",
    "en_drug_common_name": "Niacin Time Release Tablets",
    "fr_drug_brand_name": "NIODAN 500 MG COMPRIMÉS À LIBÉRATION PROLONGÉE",
    "fr_drug_common_name": "Comprimés de niacine à libération prolongée",
    "en_ingredients": "NICOTINIC ACID",
    "fr_ingredients": "Acide nicotinique",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26483,
    "drug": {
      "current_status": "DORMANT",
      "id": 16082,
      "drug_code": 76879,
      "updated_date": "2025-12-03T02:32:22-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367990,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8367989,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02283174",
      "brand_name": "ALTACE HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649004"
    },
    "created_date": "2017-10-20T19:15:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283174",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C09BA05",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2018-02-15T00:00:00-05:00",
    "actual_start_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-03-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALTACE HCT",
    "en_drug_common_name": "ALTACE HCT",
    "fr_drug_brand_name": "altace",
    "fr_drug_common_name": "altace",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nRAMIPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nRamipril",
    "drug_strength": "25.0MG\r\n5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "na",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26486,
    "drug": {
      "current_status": "MARKETED",
      "id": 1588,
      "drug_code": 13429,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251764,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02011239",
      "brand_name": "CARBOLITH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74814",
      "number_of_ais": "1",
      "ai_group_no": "0101163003"
    },
    "created_date": "2017-10-20T19:17:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02011239",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N05AN01",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-11-03T00:00:00-04:00",
    "actual_start_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2017-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-03T17:10:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOLITH CAPSULES 600MG",
    "en_drug_common_name": "CARBOLITH CAPSULES 600MG",
    "fr_drug_brand_name": "CARBOLITH CAPSULES 600MG",
    "fr_drug_common_name": "CARBOLITH CAPSULES 600MG",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "600MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "na",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26489,
    "drug": {
      "current_status": "MARKETED",
      "id": 13186,
      "drug_code": 7264,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250995,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00654531",
      "brand_name": "TRYPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65033",
      "number_of_ais": "1",
      "ai_group_no": "0111038001"
    },
    "created_date": "2017-10-20T19:18:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00654531",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "N06AX02",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-10-20T00:00:00-04:00",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_end_date": "2017-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T16:00:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRYPTAN TAB 1000MG",
    "en_drug_common_name": "TRYPTAN TAB 1000MG",
    "fr_drug_brand_name": "TRYPTAN TAB 1000MG",
    "fr_drug_common_name": "TRYPTAN TAB 1000MG",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "na",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26524,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9964,
      "drug_code": 64281,
      "updated_date": "2025-05-15T03:59:55-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8329926,
          "ingredient": {
            "id": 2174,
            "ingredient_code": 1751,
            "en_name": "INTERFERON ALFA-2B",
            "fr_name": "Interféron alfa-2b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240694",
      "brand_name": "INTRON A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118647006"
    },
    "created_date": "2017-10-23T13:13:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240694",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L03AB05",
    "atc_description": "IMMUNOSTIMULANTS",
    "anticipated_start_date": "2017-10-23T00:00:00-04:00",
    "estimated_end_date": "2017-11-24T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-18T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Limited Quantities available / Quantités limitées disponibles",
    "fr_comments": "Limited Quantities available / Quantités limitées disponibles",
    "en_drug_brand_name": "INTRON A",
    "en_drug_common_name": "interferon alfa-2b solution for injection (multi-dose pen)",
    "fr_drug_brand_name": "Intron A",
    "fr_drug_common_name": "interféron alfa-2b solution injectable  en stylo multidose",
    "en_ingredients": "INTERFERON ALFA-2B",
    "fr_ingredients": "Interféron alfa-2b",
    "drug_strength": "25000000UNIT",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "30MIU PEN",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26557,
    "drug": {
      "current_status": "MARKETED",
      "id": 190,
      "drug_code": 10494,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251345,
          "ingredient": {
            "id": 152,
            "ingredient_code": 20230,
            "en_name": "AMILORIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiloride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251344,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00784400",
      "brand_name": "AA-AMILZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70402",
      "number_of_ais": "2",
      "ai_group_no": "0213868001"
    },
    "created_date": "2017-10-23T17:19:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00784400",
    "company_name": "APOTEX INC",
    "atc_number": "C03EA01",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-11T12:14:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMILZIDE TAB",
    "en_drug_common_name": "AMILZIDE",
    "fr_drug_brand_name": "APO-AMILZIDE TAB",
    "fr_drug_common_name": "AMILZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nAMILORIDE HYDROCHLORIDE",
    "fr_ingredients": "Hydrochlorothiazide\r\nChlorhydrate d'amiloride",
    "drug_strength": "50MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26564,
    "drug": {
      "current_status": "DORMANT",
      "id": 4154,
      "drug_code": 20011,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367037,
          "ingredient": {
            "id": 1618,
            "ingredient_code": 1890,
            "en_name": "BUSPIRONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buspirone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02211076",
      "brand_name": "APO-BUSPIRONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82310",
      "number_of_ais": "1",
      "ai_group_no": "0116263001"
    },
    "created_date": "2017-10-23T17:22:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02211076",
    "company_name": "APOTEX INC",
    "atc_number": "N05BE01",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2018-01-05T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-20T16:41:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BUSPIRONE - TAB 10MG",
    "en_drug_common_name": "BUSPIRONE",
    "fr_drug_brand_name": "APO-BUSPIRONE - TAB 10MG",
    "fr_drug_common_name": "BUSPIRONE",
    "en_ingredients": "BUSPIRONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de buspirone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26569,
    "drug": {
      "current_status": "MARKETED",
      "id": 132,
      "drug_code": 10383,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251319,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00874256",
      "brand_name": "APO-DOXY TABS 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70197",
      "number_of_ais": "1",
      "ai_group_no": "0105569001"
    },
    "created_date": "2017-10-23T17:24:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00874256",
    "company_name": "APOTEX INC",
    "atc_number": "J01AA02",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2018-02-19T00:00:00-05:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T18:12:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXY TABS 100MG",
    "en_drug_common_name": "DOXYCYCLINE",
    "fr_drug_brand_name": "APO-DOXY TABS 100MG",
    "fr_drug_common_name": "DOXYCYCLINE",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26572,
    "drug": {
      "current_status": "MARKETED",
      "id": 16782,
      "drug_code": 77739,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255930,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292025",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885003"
    },
    "created_date": "2017-10-23T17:25:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292025",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB09",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-01-22T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26594,
    "drug": {
      "current_status": "MARKETED",
      "id": 9480,
      "drug_code": 6296,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250872,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00655759",
      "brand_name": "APO-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62759",
      "number_of_ais": "1",
      "ai_group_no": "0110731001"
    },
    "created_date": "2017-10-23T17:32:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00655759",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA06",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2018-01-19T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-23T02:19:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LORAZEPAM TAB 1MG",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "APO-LORAZEPAM TAB 1MG",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26625,
    "drug": {
      "current_status": "MARKETED",
      "id": 15962,
      "drug_code": 76745,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255700,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281791",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2017-10-23T17:52:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281791",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-01-15T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T14:53:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26629,
    "drug": {
      "current_status": "MARKETED",
      "id": 6970,
      "drug_code": 4732,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250673,
          "ingredient": {
            "id": 714,
            "ingredient_code": 7566,
            "en_name": "PREDNISONE",
            "fr_name": "Prednisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00312770",
      "brand_name": "APO PREDNISONE TAB 5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58588",
      "number_of_ais": "1",
      "ai_group_no": "0106321001"
    },
    "created_date": "2017-10-23T17:54:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00312770",
    "company_name": "APOTEX INC",
    "atc_number": "H02AB07",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-20T18:49:50-05:00",
    "status": "resolved",
    "en_comments": "1000 BTL is available",
    "en_drug_brand_name": "APO PREDNISONE TAB 5MG",
    "en_drug_common_name": "PREDNISONE",
    "fr_drug_brand_name": "APO PREDNISONE TAB 5MG",
    "fr_drug_common_name": "PREDNISONE",
    "en_ingredients": "PREDNISONE",
    "fr_ingredients": "Prednisone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26643,
    "drug": {
      "current_status": "MARKETED",
      "id": 23700,
      "drug_code": 86354,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258545,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02377721",
      "brand_name": "APO-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2017-10-23T18:00:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02377721",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA07",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-15T23:28:00-05:00",
    "status": "resolved",
    "en_comments": "30 BTL is available",
    "en_drug_brand_name": "APO-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "APO-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26646,
    "drug": {
      "current_status": "MARKETED",
      "id": 28562,
      "drug_code": 90681,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260362,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422093",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2017-10-23T18:01:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422093",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE08",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2017-12-18T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2017-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-29T16:06:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26652,
    "drug": {
      "current_status": "MARKETED",
      "id": 3158,
      "drug_code": 18046,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252245,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02147637",
      "brand_name": "APO-TRAZODONE TABLETS 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80260",
      "number_of_ais": "1",
      "ai_group_no": "0115713001"
    },
    "created_date": "2017-10-23T18:05:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02147637",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX05",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-10-29T00:00:00-04:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-28T15:00:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAZODONE TABLETS 50MG",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "APO-TRAZODONE TABLETS 50MG",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26662,
    "drug": {
      "current_status": "MARKETED",
      "id": 21598,
      "drug_code": 83987,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257722,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354705",
      "brand_name": "APO-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626003"
    },
    "created_date": "2017-10-23T18:10:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354705",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB11",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-02-14T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T13:29:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "APO-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26702,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16004,
      "drug_code": 76791,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342867,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282259",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2017-10-23T18:50:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282259",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX08",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-02-01T00:00:00-05:00",
    "actual_end_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-15T19:14:43-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 16157",
    "fr_comments": "Discontinued in ID 16157",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26715,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24340,
      "drug_code": 86930,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351490,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383543",
      "brand_name": "MYLAN-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2017-10-23T19:00:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02383543",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA03",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-02T18:12:02-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as per ID 20284",
    "fr_comments": "Discontinued as per ID 20284",
    "en_drug_brand_name": "MYLAN-VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "MYLAN-VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26749,
    "drug": {
      "current_status": "MARKETED",
      "id": 19868,
      "drug_code": 81202,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 17091,
        "created_date": "2021-07-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 18353,
        "mfr_code": "",
        "name": "STERI-MED PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "242, RUE SAINT-CYRILLE OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "UPTON",
        "postal_code": "J0H 2E0",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256946,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02326663",
      "brand_name": "ERYTHROMYCIN OPHTHALMIC OINTMENT USP",
      "brand_name_fr": "ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105708019"
    },
    "created_date": "2017-10-23T19:27:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326663",
    "company_name": "LABORATOIRES STERIGEN INC",
    "atc_number": "S01AA17",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2018-09-21T00:00:00-04:00",
    "actual_start_date": "2018-02-08T00:00:00-05:00",
    "actual_end_date": "2018-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-21T11:44:19-04:00",
    "status": "resolved",
    "en_comments": "Pending for analysis",
    "fr_comments": "En attente d'analyse",
    "en_drug_brand_name": "ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP",
    "en_drug_common_name": "Erythromycin ophthalmic ointment USP",
    "fr_drug_brand_name": "Onguent ophtalmique d'Érythromycin USP",
    "fr_drug_common_name": "Onguent ophtalmique d'Érythromycin USP",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3.5g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26763,
    "drug": {
      "current_status": "MARKETED",
      "id": 18786,
      "drug_code": 80046,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8256566,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02314932",
      "brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
      "brand_name_fr": "LÉVOFLOXACINE DANS DU DEXTROSE À 5% INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663001"
    },
    "created_date": "2017-10-23T20:27:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314932",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J01MA12",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2018-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-03T04:22:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "24 X 50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26767,
    "drug": {
      "current_status": "MARKETED",
      "id": 18786,
      "drug_code": 80046,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8256566,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02314932",
      "brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
      "brand_name_fr": "LÉVOFLOXACINE DANS DU DEXTROSE À 5% INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663001"
    },
    "created_date": "2017-10-23T20:31:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314932",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J01MA12",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2017-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-21T16:51:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "24 X 150 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26770,
    "drug": {
      "current_status": "MARKETED",
      "id": 22278,
      "drug_code": 84681,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8257972,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8257971,
          "ingredient": {
            "id": 2544,
            "ingredient_code": 12633,
            "en_name": "FORMOTEROL FUMARATE DIHYDRATE",
            "fr_name": "Fumarate de formotérol dihydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361760",
      "brand_name": "ZENHALE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252871004"
    },
    "created_date": "2017-10-23T20:33:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361760",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03AK09",
    "atc_description": "ADRENERGICS, INHALANTS",
    "anticipated_start_date": "2017-12-18T00:00:00-05:00",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-31T06:00:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZENHALE",
    "en_drug_common_name": "mometasone furoate & formoterol fumarate dihydrate inhalation aerosol",
    "fr_drug_brand_name": "ZENHALE",
    "fr_drug_common_name": "furoate de mométasone et fumarate de formotérol dihydraté en aérosol pour inhalation",
    "en_ingredients": "FORMOTEROL FUMARATE DIHYDRATE\r\nMOMETASONE FUROATE",
    "fr_ingredients": "Fumarate de formotérol dihydraté\r\nFuroate de mométasone",
    "drug_strength": "5MCG\r\n200MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60DOSE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26779,
    "drug": {
      "current_status": "MARKETED",
      "id": 32068,
      "drug_code": 9611,
      "updated_date": "2025-05-15T02:30:46-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251199,
          "ingredient": {
            "id": 1334,
            "ingredient_code": 4028,
            "en_name": "SODIUM POLYSTYRENE SULFONATE",
            "fr_name": "Polystyrène sulfonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00769541",
      "brand_name": "SOLYSTAT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68821",
      "number_of_ais": "1",
      "ai_group_no": "0108701001"
    },
    "created_date": "2017-10-24T01:23:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00769541",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "V03AE01",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2017-12-01T00:00:00-05:00",
    "estimated_end_date": "2018-02-07T00:00:00-05:00",
    "actual_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2018-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-05T15:33:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SOLYSTAT",
    "en_drug_common_name": "SOLYSTAT 250mg/mL SUSP 500mL",
    "fr_drug_brand_name": "SOLYSTAT",
    "fr_drug_common_name": "SOLYSTAT 250mg/mL SUSP 500mL",
    "en_ingredients": "SODIUM POLYSTYRENE SULFONATE",
    "fr_ingredients": "Polystyrène sulfonate de sodium",
    "drug_strength": "250MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26807,
    "drug": {
      "current_status": "MARKETED",
      "id": 18786,
      "drug_code": 80046,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8256566,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02314932",
      "brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
      "brand_name_fr": "LÉVOFLOXACINE DANS DU DEXTROSE À 5% INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663001"
    },
    "created_date": "2017-10-24T12:07:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314932",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J01MA12",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2017-12-07T00:00:00-05:00",
    "actual_start_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2017-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-08T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "LEVOFLOXACIN IN 5% DEXTROSE INJECTION",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "24 X 100 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26810,
    "drug": {
      "current_status": "MARKETED",
      "id": 6036,
      "drug_code": 4230,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250611,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00294748",
      "brand_name": "CALCIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57029",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2017-10-24T12:10:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00294748",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "B05XA07",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2018-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T02:33:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "CALCIUM CHLORIDE ANSYR",
    "fr_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "fr_drug_common_name": "CALCIUM CHLORIDE ANSYR",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26815,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12632,
      "drug_code": 71413,
      "updated_date": "2025-05-15T04:06:41-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337902,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247171",
      "brand_name": "BIO-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048001"
    },
    "created_date": "2017-10-24T13:28:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247171",
    "company_name": "BIOMED PHARMA",
    "atc_number": "C03AA03",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "anticipated_start_date": "2015-08-01T00:00:00-04:00",
    "actual_start_date": "2015-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-26T20:45:28-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "BIO-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "Hydrochlorothiazide",
    "fr_drug_brand_name": "BIOHYDROCHLOROTHIAZIDE",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 26818,
    "drug": {
      "current_status": "DORMANT",
      "id": 3492,
      "drug_code": 1878,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 416,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 10997,
        "mfr_code": "",
        "name": "BIOMED PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1B",
        "street_name": "9450  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365888,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00293911",
      "brand_name": "LEVATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "45312",
      "number_of_ais": "1",
      "ai_group_no": "0101524001"
    },
    "created_date": "2017-10-24T13:31:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00293911",
    "company_name": "BIOMED PHARMA",
    "anticipated_start_date": "2014-10-23T00:00:00-04:00",
    "actual_start_date": "2014-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-26T21:06:33-04:00",
    "status": "active_confirmed",
    "en_comments": "dormant",
    "en_drug_brand_name": "LEVATE",
    "en_drug_common_name": "Amitriptyline Hydrochloride",
    "fr_drug_brand_name": "LEVATE",
    "fr_drug_common_name": "Amitriptyline Hydrochloride Tablets 50 mg",
    "fr_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "drug_dosage_form_fr": "TABS",
    "drug_route_fr": "ORAL",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 26827,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23058,
      "drug_code": 85642,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8350519,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8350518,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371243",
      "brand_name": "APO-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2017-10-24T14:06:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371243",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA01",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-09-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-11T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LOSARTAN/HCTZ",
    "en_drug_common_name": "LOSARTAN/HCTZ",
    "fr_drug_brand_name": "APO-LOSARTAN/HCTZ",
    "fr_drug_common_name": "LOSARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26866,
    "drug": {
      "current_status": "MARKETED",
      "id": 49646,
      "drug_code": 92881,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 1964,
        "created_date": "2017-03-09T20:00:09-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 16391,
        "mfr_code": "",
        "name": "LINEPHARMA INTERNATIONAL LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16 UPPER WOBURN PLACE",
        "province": "GREATER LONDON",
        "country": "UNITED KINGDOM",
        "city": "LONDON",
        "postal_code": "WC1H0BS",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261359,
          "ingredient": {
            "id": 930,
            "ingredient_code": 1859,
            "en_name": "MISOPROSTOL",
            "fr_name": "Misoprostol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261358,
          "ingredient": {
            "id": 6186,
            "ingredient_code": 22628,
            "en_name": "MIFEPRISTONE",
            "fr_name": "MIFÉPRISTONE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444038",
      "brand_name": "MIFEGYMISO",
      "brand_name_fr": "MIFÉGYMISO",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257170001"
    },
    "created_date": "2017-10-24T15:22:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444038",
    "company_name": "LINEPHARMA INTERNATIONAL LIMITED",
    "atc_number": "G03XB51",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "estimated_end_date": "2017-12-31T00:00:00-05:00",
    "actual_start_date": "2017-10-24T00:00:00-04:00",
    "actual_end_date": "2018-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-01-11T17:25:28-05:00",
    "status": "resolved",
    "en_comments": "Demand increase for the drug.",
    "fr_comments": "Augmentation de la demande de produit.",
    "en_drug_brand_name": "MIFEGYMISO",
    "en_drug_common_name": "Mifepristone / Misoprostol",
    "fr_drug_brand_name": "MIFEGYMISO",
    "fr_drug_common_name": "Mifepristone / Misoprostol",
    "en_ingredients": "MISOPROSTOL\r\nMIFEPRISTONE",
    "fr_ingredients": "Misoprostol",
    "drug_strength": "200MCG\r\n200MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "BUCCAL\r\nORAL",
    "drug_route_fr": "Buccale\r\nOrale",
    "drug_package_quantity": "Combipack",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26870,
    "drug": {
      "current_status": "DORMANT",
      "id": 17392,
      "drug_code": 78453,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368101,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8368100,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8368099,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.9",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02299135",
      "brand_name": "POTASSIUM CHLORIDE 40 MEQ IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE",
      "brand_name_fr": "CHLORURE DE POTASSIUM 40 MEQ DANS DU DEXTROSE À 5% ET DU CHLORURE DE SODIUM À 0,9%",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0300097024"
    },
    "created_date": "2017-10-24T15:35:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299135",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "B05BB02",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2017-10-17T00:00:00-04:00",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-12-28T14:48:24-05:00",
    "status": "resolved",
    "en_comments": "due to manufacturing issues",
    "fr_comments": "en raison de problèmes de fabrication",
    "en_drug_brand_name": "40 (MEQ)MMOL/L POTASSIUM CHLORIDE PLUS 5% DEXTROSE & 0.9% CHLORURE DE SODIUM/SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP 079109254",
    "fr_drug_brand_name": "Hospira Healthcare",
    "fr_drug_common_name": "Chlorure de potassium dans du dextrose à 5 % et du chlorure de sodium à 0,9 % injectables 07109254",
    "en_ingredients": "DEXTROSE\r\nPOTASSIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorure de potassium\r\nChlorure de sodium",
    "drug_strength": "5.0G\r\n0.3G\r\n0.9G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 26906,
    "drug": {
      "current_status": "MARKETED",
      "id": 17420,
      "drug_code": 78474,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256139,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299364",
      "brand_name": "RIVA-OXYBUTYNIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114692001"
    },
    "created_date": "2017-10-24T19:41:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299364",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "G04BD04",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-10-31T00:00:00-04:00",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-02T14:06:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-OXYBUTYNIN",
    "en_drug_common_name": "Oxybutynin 5mg",
    "fr_drug_brand_name": "Riva-Oxybutynin",
    "fr_drug_common_name": "Oxybutynin 5mg",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 & 500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 26924,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15250,
      "drug_code": 75770,
      "updated_date": "2025-05-15T04:10:34-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341759,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02272172",
      "brand_name": "RIVA-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2017-10-24T19:51:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272172",
    "company_name": "LABORATOIRE RIVA INC",
    "atc_number": "C07AA07",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-09-04T00:00:00-04:00",
    "estimated_end_date": "2018-06-01T00:00:00-04:00",
    "actual_start_date": "2017-09-04T00:00:00-04:00",
    "actual_end_date": "2018-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-08T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-SOTALOL",
    "en_drug_common_name": "Sotalol 160mg",
    "fr_drug_brand_name": "Riva-Sotalol",
    "fr_drug_common_name": "Sotalol 160mg",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 26964,
    "drug": {
      "current_status": "MARKETED",
      "id": 5800,
      "drug_code": 3883,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 620,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 15460,
        "mfr_code": "",
        "name": "MYLAN SPECIALTY LP",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3711 COLLINS FERRY ROAD",
        "province": "WEST VIRGINIA",
        "country": "UNITED STATES",
        "city": "MORGANTOWN",
        "postal_code": "26505",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250573,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.3",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00509558",
      "brand_name": "EPIPEN",
      "brand_name_fr": "",
      "descriptor": "0.3MG/0.3ML AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "55851",
      "number_of_ais": "1",
      "ai_group_no": "0104871002"
    },
    "created_date": "2017-10-25T20:08:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00509558",
    "company_name": "MYLAN SPECIALTY LP",
    "atc_number": "C01CA24",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2017-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-16T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "EPIPEN",
    "en_drug_common_name": "EPIPEN",
    "fr_drug_brand_name": "EPIPEN",
    "fr_drug_common_name": "EPIPEN",
    "en_ingredients": "EPINEPHRINE",
    "fr_ingredients": "Épinéphrine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "Each (0.3MG/0.3ML AUTO-INJECTOR)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27072,
    "drug": {
      "current_status": "MARKETED",
      "id": 2712,
      "drug_code": 16534,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8252139,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02088398",
      "brand_name": "MYLAN-BACLOFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78432",
      "number_of_ais": "1",
      "ai_group_no": "0113246001"
    },
    "created_date": "2017-10-26T14:34:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02088398",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M03BX01",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2018-01-02T00:00:00-05:00",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-12-29T00:00:00-05:00",
    "actual_end_date": "2018-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-09T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-BACLOFEN",
    "en_drug_common_name": "BACLOFEN",
    "fr_drug_brand_name": "MYLAN-BACLOFEN",
    "fr_drug_common_name": "BACLOFEN",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27093,
    "drug": {
      "current_status": "MARKETED",
      "id": 25988,
      "drug_code": 88378,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259371,
          "ingredient": {
            "id": 1472,
            "ingredient_code": 7490,
            "en_name": "LEVONORGESTREL",
            "fr_name": "Lévonorgestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259370,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02398869",
      "brand_name": "INDAYO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0220415001"
    },
    "created_date": "2017-10-26T14:58:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398869",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA07",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2018-05-11T00:00:00-04:00",
    "estimated_end_date": "2018-08-23T00:00:00-04:00",
    "actual_start_date": "2018-05-14T00:00:00-04:00",
    "actual_end_date": "2018-08-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T11:41:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "INDAYO",
    "en_drug_common_name": "INDAYO",
    "fr_drug_brand_name": "INDAYO",
    "fr_drug_common_name": "INDAYO",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nLEVONORGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nLévonorgestrel",
    "drug_strength": "0.03MG\r\n0.15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "91BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27102,
    "drug": {
      "current_status": "MARKETED",
      "id": 11774,
      "drug_code": 69229,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254373,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245214",
      "brand_name": "VITAMIN C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108469006"
    },
    "created_date": "2017-10-26T15:01:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245214",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A11GA01",
    "atc_description": "ASCORBIC ACID (VIT C), INCL COMBINATIONS",
    "anticipated_start_date": "2018-05-16T00:00:00-04:00",
    "estimated_end_date": "2018-07-27T00:00:00-04:00",
    "actual_start_date": "2018-05-04T00:00:00-04:00",
    "actual_end_date": "2018-07-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-21T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VITAMIN C",
    "en_drug_common_name": "VITAMIN C",
    "fr_drug_brand_name": "VITAMIN C",
    "fr_drug_common_name": "VITAMIN C",
    "en_ingredients": "VITAMIN C",
    "fr_ingredients": "Vitamine C",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "50ML 1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27110,
    "drug": {
      "current_status": "MARKETED",
      "id": 25962,
      "drug_code": 88340,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259363,
          "ingredient": {
            "id": 3074,
            "ingredient_code": 13247,
            "en_name": "ALMOTRIPTAN",
            "fr_name": "Almotriptan (Malate d'almotriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02398443",
      "brand_name": "MYLAN-ALMOTRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149521002"
    },
    "created_date": "2017-10-26T15:03:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398443",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N02CC05",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2018-03-05T00:00:00-05:00",
    "estimated_end_date": "2019-01-18T00:00:00-05:00",
    "actual_start_date": "2018-03-07T00:00:00-05:00",
    "actual_end_date": "2019-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-22T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ALMOTRIPTAN",
    "en_drug_common_name": "ALMOTRIPTAN",
    "fr_drug_brand_name": "MYLAN-ALMOTRIPTAN",
    "fr_drug_common_name": "ALMOTRIPTAN",
    "en_ingredients": "ALMOTRIPTAN",
    "fr_ingredients": "ALMOTRIPTAN",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27117,
    "drug": {
      "current_status": "MARKETED",
      "id": 10792,
      "drug_code": 66607,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254081,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242784",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506002"
    },
    "created_date": "2017-10-26T15:05:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242784",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB01",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2018-04-24T00:00:00-04:00",
    "estimated_end_date": "2018-05-25T00:00:00-04:00",
    "actual_start_date": "2018-04-27T00:00:00-04:00",
    "actual_end_date": "2018-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T20:10:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27146,
    "drug": {
      "current_status": "MARKETED",
      "id": 25060,
      "drug_code": 87574,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259082,
          "ingredient": {
            "id": 2826,
            "ingredient_code": 12026,
            "en_name": "RILUZOLE",
            "fr_name": "Riluzole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390299",
      "brand_name": "MYLAN-RILUZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141861001"
    },
    "created_date": "2017-10-26T15:24:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390299",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N07XX02",
    "atc_description": "OTHER NERVOUS SYSTEM DRUGS",
    "anticipated_start_date": "2018-01-31T00:00:00-05:00",
    "estimated_end_date": "2018-03-09T00:00:00-05:00",
    "actual_start_date": "2018-01-31T00:00:00-05:00",
    "actual_end_date": "2018-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-10T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RILUZOLE",
    "en_drug_common_name": "RILUZOLE",
    "fr_drug_brand_name": "MYLAN-RILUZOLE",
    "fr_drug_common_name": "RILUZOLE",
    "en_ingredients": "RILUZOLE",
    "fr_ingredients": "Riluzole",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27153,
    "drug": {
      "current_status": "MARKETED",
      "id": 19030,
      "drug_code": 80298,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256661,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317451",
      "brand_name": "MINT-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2017-10-26T17:51:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317451",
    "company_name": "MINT PHARMACEUTICALS INC",
    "actual_start_date": "2017-06-30T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-01-31T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "Mint-Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "fr_ingredients": "Pravastatin Na",
    "drug_dosage_form_fr": "Tablets",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "Bottles of 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27157,
    "drug": {
      "current_status": "MARKETED",
      "id": 19032,
      "drug_code": 80299,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256662,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317478",
      "brand_name": "MINT-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2017-10-26T18:09:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317478",
    "company_name": "MINT PHARMACEUTICALS INC",
    "actual_start_date": "2017-06-30T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-01-31T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "Mint-Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "fr_ingredients": "Pravastatin Na",
    "drug_dosage_form_fr": "Tablets",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "Bottles of 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27161,
    "drug": {
      "current_status": "MARKETED",
      "id": 19034,
      "drug_code": 80300,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256663,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317486",
      "brand_name": "MINT-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-10-26T18:13:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317486",
    "company_name": "MINT PHARMACEUTICALS INC",
    "actual_start_date": "2017-06-30T00:00:00-04:00",
    "actual_end_date": "2018-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-01-31T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "Mint-Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "fr_ingredients": "Pravastatin Na",
    "drug_dosage_form_fr": "Tablets",
    "drug_route_fr": "Oral",
    "drug_package_quantity": "Bottles of 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27164,
    "drug": {
      "current_status": "MARKETED",
      "id": 17958,
      "drug_code": 79079,
      "updated_date": "2025-05-15T02:32:06-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256304,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02305259",
      "brand_name": "MINT-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120003"
    },
    "created_date": "2017-10-26T18:18:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305259",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "A04AA01",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "actual_start_date": "2017-07-14T00:00:00-04:00",
    "actual_end_date": "2018-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-10T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ONDANSETRON",
    "en_drug_common_name": "Ondansetron",
    "fr_drug_brand_name": "Mint-Ondansetron",
    "fr_drug_common_name": "Ondansetron",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27173,
    "drug": {
      "current_status": "MARKETED",
      "id": 17960,
      "drug_code": 79080,
      "updated_date": "2025-05-15T02:32:06-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256305,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02305267",
      "brand_name": "MINT-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120001"
    },
    "created_date": "2017-10-26T18:21:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305267",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "A04AA01",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "actual_start_date": "2017-07-14T00:00:00-04:00",
    "actual_end_date": "2017-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-22T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ONDANSETRON",
    "en_drug_common_name": "Ondansetron",
    "fr_drug_brand_name": "Mint-Ondansetron",
    "fr_drug_common_name": "Ondansetron",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27176,
    "drug": {
      "current_status": "MARKETED",
      "id": 28666,
      "drug_code": 90798,
      "updated_date": "2025-12-03T00:32:32-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260402,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423243",
      "brand_name": "MINT-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-10-26T18:24:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423243",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AX09",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2017-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-EZETIMIBE",
    "en_drug_common_name": "Ezetimibe",
    "fr_drug_brand_name": "Mint-Ezetimibe",
    "fr_drug_common_name": "Ezerimibe",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27179,
    "drug": {
      "current_status": "MARKETED",
      "id": 10382,
      "drug_code": 65585,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253928,
          "ingredient": {
            "id": 2778,
            "ingredient_code": 8923,
            "en_name": "EPINEPHRINE BITARTRATE",
            "fr_name": "Bitartrate d'épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.182",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253927,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241915",
      "brand_name": "MARCAINE E",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231290001"
    },
    "created_date": "2017-10-26T20:16:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241915",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N01BB51",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2017-11-29T00:00:00-05:00",
    "actual_end_date": "2018-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-17T13:04:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MARCAINE E",
    "en_drug_common_name": "MARCAINE E 0.25%",
    "fr_drug_brand_name": "MARCAINE E",
    "fr_drug_common_name": "MARCAINE E 0.25%",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE BITARTRATE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nBitartrate d'épinéphrine",
    "drug_strength": "2.5MG\r\n9.1MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27184,
    "drug": {
      "current_status": "MARKETED",
      "id": 8708,
      "drug_code": 60601,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253512,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237280",
      "brand_name": "EFFEXOR XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2017-10-26T20:18:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237280",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N06AX16",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-12-20T00:00:00-05:00",
    "actual_end_date": "2018-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-20T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Other presentations available: Effexor 37.5mg",
    "fr_comments": "Autre présentation disponible: Effexor 37.5mg",
    "en_drug_brand_name": "EFFEXOR XR",
    "en_drug_common_name": "EFFEXOR",
    "fr_drug_brand_name": "EFFEXOR XR",
    "fr_drug_common_name": "EFFEXOR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27239,
    "drug": {
      "current_status": "MARKETED",
      "id": 7856,
      "drug_code": 51066,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253411,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231689",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2017-10-27T13:47:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231689",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C07AG01",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2017-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-11-19T22:09:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "LABETALOL",
    "fr_drug_brand_name": "LABETALOL",
    "fr_drug_common_name": "LABETALOL",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 X 25ml VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27242,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14144,
      "drug_code": 74194,
      "updated_date": "2025-05-15T04:09:01-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8340260,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02256711",
      "brand_name": "RANITIDINE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150004"
    },
    "created_date": "2017-10-27T13:53:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256711",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BA02",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-09-25T00:00:00-04:00",
    "actual_end_date": "2017-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T02:39:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RANITIDINE INJECTION USP",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "RANITIDINE",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "50ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27249,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22140,
      "drug_code": 84501,
      "updated_date": "2025-05-15T04:17:43-04:00",
      "company": {
        "id": 1216,
        "created_date": "2017-03-09T13:23:57-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 12463,
        "mfr_code": "",
        "name": "GENMED A DIVISION OF PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-800-387-4974\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8349620,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360039",
      "brand_name": "GD-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2017-10-27T14:19:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360039",
    "company_name": "GENMED A DIVISION OF PFIZER CANADA INC",
    "atc_number": "N06AX16",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-25T06:00:06-05:00",
    "status": "resolved",
    "en_comments": "Other presentations available: GD-Venlafaxine 37.5mg",
    "fr_comments": "Autre présentation disponible: GD-Venlafaxine 37.5mg",
    "en_drug_brand_name": "GD-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE",
    "fr_drug_brand_name": "GD-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27274,
    "drug": {
      "current_status": "MARKETED",
      "id": 13266,
      "drug_code": 72841,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 1080,
        "created_date": "2017-03-09T13:23:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 3652,
        "mfr_code": "",
        "name": "DENTSPLY CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1",
        "street_name": "525 ROWNTREE DAIRY ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 7K6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254816,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.005",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8254815,
          "ingredient": {
            "id": 1256,
            "ingredient_code": 308,
            "en_name": "ARTICAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'articaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248489",
      "brand_name": "4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0226661002"
    },
    "created_date": "2017-10-27T17:27:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248489",
    "company_name": "DENTSPLY CANADA LIMITED",
    "atc_number": "N01BB58",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-03-01T00:00:00-05:00",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-30T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",
    "en_drug_common_name": "Articaine Hydrochloride 40 mg/mL and Epinephrine Injection 1:200,000",
    "fr_drug_brand_name": "Astracaine Dentaire à 4% et Épinéphrine 1:200 000 (0,005 mg/mL)",
    "fr_drug_common_name": "Chlorhydrate d’articaïne et bitartrate d’épinéphrine injectable",
    "en_ingredients": "ARTICAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate d'articaïne\r\nÉpinéphrine",
    "drug_strength": "40MG\r\n0.005MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "100 1.8 mL cartridges/box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27310,
    "drug": {
      "current_status": "MARKETED",
      "id": 18690,
      "drug_code": 79957,
      "updated_date": "2025-12-03T00:31:20-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256537,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314053",
      "brand_name": "SPC-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618003"
    },
    "created_date": "2017-10-27T18:00:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314053",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N04BC04",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-10-27T00:00:00-04:00",
    "actual_start_date": "2017-10-27T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T19:53:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ROPINIROLE",
    "en_drug_common_name": "RAN-ROPINIROLE",
    "fr_drug_brand_name": "RAN-ROPINIROLE",
    "fr_drug_common_name": "RAN-ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27313,
    "drug": {
      "current_status": "MARKETED",
      "id": 8416,
      "drug_code": 585,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250158,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001732",
      "brand_name": "XYLOCAINE 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23886",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2017-10-27T18:01:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001732",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB02",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2018-03-16T00:00:00-04:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-04T19:54:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE 1%",
    "en_drug_common_name": "Xylocaine® 1% Plain 50x10mL SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "Xylocaine® 1% Plain 50x10mL SU Polyamp® Duofit®",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "50x10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27316,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27648,
      "drug_code": 89877,
      "updated_date": "2025-12-03T01:31:46-05:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353778,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414104",
      "brand_name": "RAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-10-27T18:02:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414104",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N05AH03",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-10-27T00:00:00-04:00",
    "estimated_end_date": "2018-10-08T00:00:00-04:00",
    "actual_start_date": "2017-10-27T00:00:00-04:00",
    "actual_end_date": "2018-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T19:08:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-OLANZAPINE ODT",
    "en_drug_common_name": "RAN-OLANZAPINE ODT",
    "fr_drug_brand_name": "RAN-OLANZAPINE ODT",
    "fr_drug_common_name": "RAN-OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27323,
    "drug": {
      "current_status": "MARKETED",
      "id": 16792,
      "drug_code": 77754,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255935,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292173",
      "brand_name": "PMS-AMIODARONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593003"
    },
    "created_date": "2017-10-27T18:18:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292173",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C01BD01",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2018-04-26T00:00:00-04:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-AMIODARONE",
    "en_drug_common_name": "AMIODARONE",
    "fr_drug_brand_name": "PMS-AMIODARONE",
    "fr_drug_common_name": "AMIODARONE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27326,
    "drug": {
      "current_status": "MARKETED",
      "id": 31762,
      "drug_code": 9418,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251162,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00654507",
      "brand_name": "PMS-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68486",
      "number_of_ais": "1",
      "ai_group_no": "0101524003"
    },
    "created_date": "2017-10-27T18:19:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00654507",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AA09",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-11-23T00:00:00-05:00",
    "actual_start_date": "2017-10-27T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T19:19:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-AMITRIPTYLINE",
    "en_drug_common_name": "AMITRIPTYLINE",
    "fr_drug_brand_name": "PMS-AMITRIPTYLINE",
    "fr_drug_common_name": "AMITRIPTYLINE",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27329,
    "drug": {
      "current_status": "MARKETED",
      "id": 14440,
      "drug_code": 74701,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255200,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261634",
      "brand_name": "PMS-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-10-27T18:20:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261634",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01FA10",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-26T15:55:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "PMS-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27333,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13088,
      "drug_code": 72455,
      "updated_date": "2025-05-15T04:07:40-04:00",
      "company": {
        "id": 224,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4569,
        "mfr_code": "MCL08",
        "name": "MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "88 MCNABB STREET",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 5L2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338819,
          "ingredient": {
            "id": 3074,
            "ingredient_code": 13247,
            "en_name": "ALMOTRIPTAN",
            "fr_name": "Almotriptan (Malate d'almotriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248128",
      "brand_name": "AXERT 6.25MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149521001"
    },
    "created_date": "2017-10-27T18:24:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248128",
    "company_name": "MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",
    "atc_number": "N02CC05",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "discontinuation_date": "2017-10-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All stock has been depleted.",
    "fr_supply_disruption_mitigation": "All stock has been depleted.",
    "en_discontinuation_comments": "J&J North American decision to exit the business.",
    "fr_discontinuation_comments": "J&J North American decision to exit business.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AXERT 6.25MG",
    "en_drug_common_name": "AXERT",
    "fr_drug_brand_name": "AXERT 6.25MG",
    "fr_drug_common_name": "AXERT",
    "en_ingredients": "ALMOTRIPTAN",
    "fr_ingredients": "ALMOTRIPTAN",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 TABLETS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27336,
    "drug": {
      "current_status": "MARKETED",
      "id": 2370,
      "drug_code": 15548,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252041,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02063743",
      "brand_name": "PMS-BACLOFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77243",
      "number_of_ais": "1",
      "ai_group_no": "0113246002"
    },
    "created_date": "2017-10-27T18:27:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02063743",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M03BX01",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "estimated_end_date": "2018-02-12T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-17T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-BACLOFEN TAB 20MG",
    "en_drug_common_name": "BACLOFEN",
    "fr_drug_brand_name": "PMS-BACLOFEN TAB 20MG",
    "fr_drug_common_name": "BACLOFEN",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27339,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 234,
      "drug_code": 10575,
      "updated_date": "2025-12-03T01:04:56-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8286885,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00848417",
      "brand_name": "PMS-DOCUSATE SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70572",
      "number_of_ais": "1",
      "ai_group_no": "0104351005"
    },
    "created_date": "2017-10-27T18:31:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00848417",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA02",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2017-11-28T00:00:00-05:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T11:15:56-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-DOCUSATE SODIUM",
    "en_drug_common_name": "DOCUSATE SODIUM",
    "fr_drug_brand_name": "PMS-DOCUSATE SODIUM",
    "fr_drug_common_name": "DOCUSATE SODIUM",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27343,
    "drug": {
      "current_status": "MARKETED",
      "id": 18996,
      "drug_code": 80258,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256649,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317079",
      "brand_name": "PMS-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2017-10-27T18:32:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317079",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T19:19:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "PMS-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27346,
    "drug": {
      "current_status": "MARKETED",
      "id": 18996,
      "drug_code": 80258,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256649,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317079",
      "brand_name": "PMS-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2017-10-27T18:33:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317079",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09CA04",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2018-03-02T00:00:00-05:00",
    "actual_start_date": "2017-10-27T00:00:00-04:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T14:35:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "PMS-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27351,
    "drug": {
      "current_status": "MARKETED",
      "id": 17686,
      "drug_code": 78754,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256211,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02302209",
      "brand_name": "PMS-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2017-10-27T18:34:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302209",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA07",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-12-14T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T19:20:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "PMS-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27354,
    "drug": {
      "current_status": "MARKETED",
      "id": 13808,
      "drug_code": 73690,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254963,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02252007",
      "brand_name": "PMS-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332006"
    },
    "created_date": "2017-10-27T18:34:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02252007",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AX08",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-12-07T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2017-12-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-15T19:04:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "PMS-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27357,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13090,
      "drug_code": 72456,
      "updated_date": "2025-05-15T04:07:40-04:00",
      "company": {
        "id": 224,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4569,
        "mfr_code": "MCL08",
        "name": "MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "88 MCNABB STREET",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 5L2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338820,
          "ingredient": {
            "id": 3074,
            "ingredient_code": 13247,
            "en_name": "ALMOTRIPTAN",
            "fr_name": "Almotriptan (Malate d'almotriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248129",
      "brand_name": "AXERT 12.5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149521002"
    },
    "created_date": "2017-10-27T18:35:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248129",
    "company_name": "MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",
    "atc_number": "N02CC05",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "discontinuation_date": "2017-10-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All stock depleted.",
    "fr_supply_disruption_mitigation": "All stock depleted.",
    "en_discontinuation_comments": "J&J North American to exit business.",
    "fr_discontinuation_comments": "J&J North American to exit business.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AXERT 12.5MG",
    "en_drug_common_name": "AXERT",
    "fr_drug_brand_name": "AXERT 12.5MG",
    "fr_drug_common_name": "AXERT",
    "en_ingredients": "ALMOTRIPTAN",
    "fr_ingredients": "ALMOTRIPTAN",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 TABLETS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27359,
    "drug": {
      "current_status": "MARKETED",
      "id": 23774,
      "drug_code": 86433,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258566,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378531",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-10-27T18:35:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378531",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA07",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-06-10T00:00:00-04:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-18T19:35:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27364,
    "drug": {
      "current_status": "MARKETED",
      "id": 27438,
      "drug_code": 89674,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259927,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02412179",
      "brand_name": "PMS-SILDENAFIL R",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261004"
    },
    "created_date": "2017-10-27T18:36:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02412179",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C02KX",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "estimated_end_date": "2018-03-07T00:00:00-05:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T15:04:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SILDENAFIL R",
    "en_drug_common_name": "SILDENAFIL-R",
    "fr_drug_brand_name": "PMS-SILDENAFIL R",
    "fr_drug_common_name": "SILDENAFIL R",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFILE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27368,
    "drug": {
      "current_status": "MARKETED",
      "id": 14562,
      "drug_code": 74842,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255235,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02263017",
      "brand_name": "PMS-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938006"
    },
    "created_date": "2017-10-27T18:38:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02263017",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX11",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-02-22T00:00:00-05:00",
    "actual_start_date": "2017-10-09T00:00:00-04:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "PMS-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27374,
    "drug": {
      "current_status": "MARKETED",
      "id": 17714,
      "drug_code": 78792,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256227,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302624",
      "brand_name": "PMS-DICLOFENAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2017-10-27T18:39:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02302624",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M01AB05",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "NO REMAINING SUPPLY",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-27T18:39:22-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-DICLOFENAC",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "PMS-DICLOFENAC",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27377,
    "drug": {
      "current_status": "MARKETED",
      "id": 7434,
      "drug_code": 50031,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253310,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230768",
      "brand_name": "PMS-VALPROIC ACID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996001"
    },
    "created_date": "2017-10-27T18:41:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02230768",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AG01",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "250mg in format 100 still available",
    "fr_discontinuation_comments": "250MG EN 100 TOUJOURS DISPONIBLE",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-27T18:41:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-VALPROIC ACID",
    "en_drug_common_name": "VALPROIC ACID",
    "fr_drug_brand_name": "PMS-VALPROIC ACID",
    "fr_drug_common_name": "VALPROIC ACID",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 27502,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17388,
      "drug_code": 78451,
      "updated_date": "2025-05-15T04:12:55-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344472,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.9",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8344471,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02299119",
      "brand_name": "POTASSIUM CHLORIDE 40 MEQ IN 0.9% SODIUM CHLORIDE",
      "brand_name_fr": "CHLORURE DE POTASSIUM 40 MEQ DANS DU CHLORURE DE SODIUM À 0.9%",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0213340006"
    },
    "created_date": "2017-10-30T15:05:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02299119",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "B05BB01",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2018-03-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-11-29T13:46:27-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "40(MEQ)MMOL/L POTASSIUM CHLORIDE IN/ET 0.9% CHLORURE DE SODIUM/SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "Potassium Chloride in 0.9% Sodium IN/ET 0.9% Chlorure De Sodium/Sodium Chlorure",
    "fr_drug_brand_name": "Hospira Healthcare Corporation",
    "fr_drug_common_name": "Chlorure de potassium dans du chlorure de sodium à 0,9 % injectables",
    "en_ingredients": "POTASSIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium\r\nChlorure de sodium",
    "drug_strength": "0.3G\r\n0.9G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27549,
    "drug": {
      "current_status": "MARKETED",
      "id": 21480,
      "drug_code": 83855,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257672,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353350",
      "brand_name": "LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843002"
    },
    "created_date": "2017-10-31T13:13:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353350",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX14",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-11-07T00:00:00-05:00",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_end_date": "2017-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-10T15:19:09-05:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM TAB",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM COMPRIMES",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27583,
    "drug": {
      "current_status": "APPROVED",
      "id": 21020,
      "drug_code": 83251,
      "updated_date": "2025-12-03T02:21:59-05:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8360899,
          "ingredient": {
            "id": 3638,
            "ingredient_code": 13301,
            "en_name": "EPTACOG ALFA",
            "fr_name": "Eptacog alfa (activé)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02347113",
      "brand_name": "NIASTASE RT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136061004"
    },
    "created_date": "2017-10-31T14:13:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347113",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "B02BD08",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "discontinuation_date": "2017-10-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "no supply remaining",
    "fr_supply_disruption_mitigation": "aucun restant",
    "en_discontinuation_comments": "The drug product is available as Niastase RT powder vial/pre-filled solvent syringe presentation",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-31T14:15:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIASTASE RT",
    "en_drug_common_name": "Eptacog Alfa (activated)",
    "fr_drug_brand_name": "Niastase RT powder vial/solvent vial presentation",
    "fr_drug_common_name": "Eptacog Alfa (activated)",
    "en_ingredients": "EPTACOG ALFA",
    "fr_ingredients": "fRVIIa",
    "drug_strength": "1MG",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "One vial of 1mg (50 KIU) per carton",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27590,
    "drug": {
      "current_status": "APPROVED",
      "id": 21022,
      "drug_code": 83252,
      "updated_date": "2025-12-03T02:21:59-05:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8360900,
          "ingredient": {
            "id": 3638,
            "ingredient_code": 13301,
            "en_name": "EPTACOG ALFA",
            "fr_name": "Eptacog alfa (activé)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02347121",
      "brand_name": "NIASTASE RT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136061005"
    },
    "created_date": "2017-10-31T14:17:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347121",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "B02BD08",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "discontinuation_date": "2017-10-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "no supply remaining",
    "fr_supply_disruption_mitigation": "aucun restant",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-31T14:34:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIASTASE RT",
    "en_drug_common_name": "Eptacog Alfa (activated)",
    "fr_drug_brand_name": "Niastase RT powder vial/solvent vial presentation",
    "fr_drug_common_name": "Eptacog Alfa (activated)",
    "en_ingredients": "EPTACOG ALFA",
    "fr_ingredients": "rFVIIa",
    "drug_strength": "2MG",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "One vial of 2mg (100 KIU) per carton",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27606,
    "drug": {
      "current_status": "APPROVED",
      "id": 21024,
      "drug_code": 83253,
      "updated_date": "2025-12-03T02:21:59-05:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8360901,
          "ingredient": {
            "id": 3638,
            "ingredient_code": 13301,
            "en_name": "EPTACOG ALFA",
            "fr_name": "Eptacog alfa (activé)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02347148",
      "brand_name": "NIASTASE RT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136061003"
    },
    "created_date": "2017-10-31T14:35:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347148",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "B02BD08",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "discontinuation_date": "2017-10-27T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "no supply remaining",
    "fr_supply_disruption_mitigation": "aucun restant",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-31T14:35:58-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NIASTASE RT",
    "en_drug_common_name": "Eptacog Alfa (activated)",
    "fr_drug_brand_name": "Niastase RT powder vial/solvent vial presentation",
    "fr_drug_common_name": "Eptacog Alfa (activated)",
    "en_ingredients": "EPTACOG ALFA",
    "fr_ingredients": "rFVIIa",
    "drug_strength": "5MG",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "One vial of 5mg (250 KIU) per carton",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27609,
    "drug": {
      "current_status": "MARKETED",
      "id": 19604,
      "drug_code": 80973,
      "updated_date": "2025-05-15T02:32:21-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256832,
          "ingredient": {
            "id": 854,
            "ingredient_code": 6161,
            "en_name": "HYDROCODONE BITARTRATE",
            "fr_name": "Bitartrate d'hydrocodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02324253",
      "brand_name": "PDP-HYDROCODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107555001"
    },
    "created_date": "2017-10-31T18:44:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324253",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "R05DA03",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2017-10-30T00:00:00-04:00",
    "estimated_end_date": "2017-12-28T00:00:00-05:00",
    "actual_start_date": "2017-10-30T00:00:00-04:00",
    "actual_end_date": "2018-01-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-08T05:58:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-HYDROCODONE",
    "en_drug_common_name": "pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL",
    "fr_drug_brand_name": "pdp-HYDROCODONE BITAR",
    "fr_drug_common_name": "pdp-HYDROCODONE BITAR 1mg/mL SYR 500mL",
    "en_ingredients": "HYDROCODONE BITARTRATE",
    "fr_ingredients": "Bitartrate d'hydrocodone",
    "drug_strength": "1MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 27626,
    "drug": {
      "current_status": "MARKETED",
      "id": 12792,
      "drug_code": 71771,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254671,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247521",
      "brand_name": "EZETROL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-10-31T19:45:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247521",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C10AX09",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "estimated_end_date": "2017-11-06T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-07T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "EZETROL",
    "en_drug_common_name": "ezetimibe tablets",
    "fr_drug_brand_name": "EZETROL",
    "fr_drug_common_name": "comprimés d’ézétimibe",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "tier_3": false
  }
]